@NP	changes	10
@NP	spinal cord morphology	21
@NP	T4 transection	50
@NP	olfactory ensheathing cell transplantation Tomas	69
@NP	Kalincik a	120
@NP	Katarina Jozefcikova a	134
@NP	Katarina Jozefcikova	134
@NP	a	155
@NP	Ratneswary Sutharsan b	158
@NP	Ratneswary Sutharsan	158
@NP	b	179
@NP	Alan Mackay-Sim b	182
@NP	Pascal Carrive a	201
@NP	Pascal Carrive	201
@NP	a	216
@NP	Phil M.E.	219
@NP	Waite a a School of Medical Sciences	229
@NP	Waite a	229
@NP	a School of Medical Sciences	237
@NP	a School	237
@NP	Medical Sciences	249
@NP	University of New South Wales	267
@NP	University	267
@NP	New South Wales	281
@NP	Sydney , NSW 2052	298
@NP	Sydney	298
@NP	NSW 2052	306
@NP	Australia b National Centre for Adult Stem Cell Research	316
@NP	Australia b National Centre	316
@NP	Adult Stem Cell Research	348
@NP	Eskitis Institute for Cell	374
@NP	Eskitis Institute	374
@NP	Cell	396
@NP	Molecular Therapies , Griffith University , Nathan , QLD 4111 , Australia a b	405
@NP	Molecular Therapies	405
@NP	Griffith University	426
@NP	Nathan	447
@NP	QLD 4111	455
@NP	Australia a b	465
@NP	Australia	465
@NP	a b	477
@NP	t r	483
@NP	a c t Spinal cord transection at T4	487
@NP	a c t Spinal cord transection	487
@NP	T4	520
@NP	severe damage of the nervous tissue	534
@NP	severe damage	534
@NP	the nervous tissue	551
@NP	impairment of motor , sensory and autonomic functions	576
@NP	impairment	576
@NP	motor , sensory and autonomic functions	590
@NP	Transplantation of olfactory ensheathing cells -LRB- OECs -RRB-	630
@NP	Transplantation of olfactory ensheathing cells	630
@NP	Transplantation	630
@NP	olfactory ensheathing cells	649
@NP	OECs	678
@NP	these functions	713
@NP	a number	737
@NP	mechanisms , which include facilitation of regeneration and neuroprotection	749
@NP	mechanisms	749
@NP	facilitation of regeneration and neuroprotection	775
@NP	facilitation	775
@NP	regeneration and neuroprotection	791
@NP	cardiovascular functions	829
@NP	we	855
@NP	OECs	885
@NP	the duration of autonomic dysreflexia	897
@NP	the duration	897
@NP	autonomic dysreflexia	913
@NP	evidence of regeneration	944
@NP	evidence	944
@NP	regeneration	956
@NP	the mechanisms underpinning this improvement	992
@NP	the mechanisms	992
@NP	this improvement	1020
@NP	we	1038
@NP	changes	1054
@NP	selected morphological features	1065
@NP	cavitation , non-cavity tissue loss	1098
@NP	cavitation	1098
@NP	non-cavity tissue loss	1110
@NP	morphology of sympathetic preganglionic neurons	1134
@NP	morphology	1134
@NP	sympathetic preganglionic neurons	1148
@NP	primary afferent fibre density	1186
@NP	the T4-transected rat spinal cord over 9 weeks	1221
@NP	the T4-transected rat spinal cord	1221
@NP	9 weeks	1260
@NP	control and OEC-transplanted animals	1277
@NP	T4 transection	1315
@NP	a number of structural changes	1337
@NP	a number	1337
@NP	structural changes	1349
@NP	gradual formation of cavities , non-cavity tissue loss	1369
@NP	gradual formation	1369
@NP	cavities , non-cavity tissue loss	1390
@NP	cavities	1390
@NP	non-cavity tissue loss	1400
@NP	a long-term increase in soma size of sympathetic preganglionic neurons	1424
@NP	a long-term increase	1424
@NP	soma size of sympathetic preganglionic neurons	1448
@NP	soma size	1448
@NP	sympathetic preganglionic neurons	1461
@NP	a temporary increase in the extent of their dendritic arbours	1499
@NP	a temporary increase	1499
@NP	the extent of their dendritic arbours	1523
@NP	the extent	1523
@NP	their dendritic arbours	1537
@NP	an increase in the density of primary afferent fibres	1566
@NP	an increase	1566
@NP	the density of primary afferent fibres	1581
@NP	the density	1581
@NP	primary afferent fibres	1596
@NP	the lesion	1630
@NP	OECs	1642
@NP	the cavitation and normalised soma size of the sympathetic preganglionic neurons	1657
@NP	the cavitation and normalised soma size	1657
@NP	the sympathetic preganglionic neurons	1700
@NP	the lesion	1744
@NP	the extent of dendritic arbours	1773
@NP	the extent	1773
@NP	dendritic arbours	1787
@NP	the preganglionic neurons above the lesion	1808
@NP	the preganglionic neurons	1808
@NP	the lesion	1840
@NP	the OECs	1857
@NP	the normalisation of the dysreflexic hypertension	1884
@NP	the normalisation	1884
@NP	the dysreflexic hypertension	1905
@NP	tissue preservation	1942
@NP	normalisation of the morphology of the preganglionic neurons	1966
@NP	normalisation	1966
@NP	the morphology of the preganglionic neurons	1983
@NP	the morphology	1983
@NP	the preganglionic neurons	2001
@NP	the lesion	2037
@NP	the input	2065
@NP	the rostral preganglionic neurons , whose vasomotor control remains intact	2078
@NP	the rostral preganglionic neurons	2078
@NP	vasomotor control	2119
@NP	We	2153
@NP	these changes	2173
@NP	secretion of soluble trophic factors	2208
@NP	secretion	2208
@NP	soluble trophic factors	2221
@NP	the transplanted OECs	2248
@NP	Introduction Spinal cord injury -LRB- SCI -RRB-	2275
@NP	Introduction Spinal cord injury	2275
@NP	Introduction	2275
@NP	Spinal cord injury	2288
@NP	SCI	2308
@NP	both immediate and delayed neural tissue loss	2322
@NP	impairment of sensory , motor and autonomic functions	2382
@NP	impairment	2382
@NP	sensory , motor and autonomic functions	2396
@NP	tissue loss	2453
@NP	the formation	2480
@NP	cavities within the spinal cord	2497
@NP	cavities	2497
@NP	the spinal cord	2513
@NP	an overall shrinkage	2540
@NP	the nervous tissue adjacent to the injury site	2564
@NP	the nervous tissue	2564
@NP	the injury site	2595
@NP	Kakulas , 1999 ; Potas et al. , 2006	2612
@NP	Kakulas	2612
@NP	1999 ; Potas et al.	2621
@NP	1999	2621
@NP	Potas et al.	2627
@NP	Potas	2627
@NP	et al.	2633
@NP	2006	2641
@NP	tissue loss	2656
@NP	the development of secondary injury	2669
@NP	the development	2669
@NP	secondary injury	2688
@NP	plastic changes	2724
@NP	neuronal systems not directly disrupted by the traumatic event	2743
@NP	neuronal systems	2743
@NP	the traumatic event	2786
@NP	example	2811
@NP	primary afferent fibres	2833
@NP	the dorsal horn and plasticity of propriospinal connections	2864
@NP	the dorsal horn and plasticity	2864
@NP	propriospinal connections	2898
@NP	4 weeks of the SCI	2937
@NP	4 weeks	2937
@NP	the SCI	2948
@NP	the spinal segments	2959
@NP	the injury	2989
@NP	Cameron	3001
@NP	et al. , 2006 ; Hou et al. , 2008 ; Hou et al. , 2009 ; Krenz et al. , 1999	3009
@NP	et al. , 2006	3009
@NP	et al.	3009
@NP	2006	3017
@NP	Hou et al. , 2008	3023
@NP	Hou	3023
@NP	et al. , 2008	3027
@NP	et al.	3027
@NP	2008	3035
@NP	Hou et al. , 2009	3041
@NP	Hou	3041
@NP	et al. , 2009	3045
@NP	et al.	3045
@NP	2009	3053
@NP	Krenz et al. , 1999	3059
@NP	Krenz	3059
@NP	et al. , 1999	3065
@NP	et al.	3065
@NP	1999	3073
@NP	changes	3093
@NP	the morphology of the sympathetic preganglionic neurons -LRB- SPNs -RRB-	3104
@NP	the morphology	3104
@NP	the sympathetic preganglionic neurons -LRB- SPNs -RRB-	3122
@NP	the sympathetic preganglionic neurons	3122
@NP	SPNs	3161
@NP	the early post-injury period	3184
@NP	Krassioukov andWeaver , 1996 ; Krenz andWeaver , 1998a	3214
@NP	Krassioukov andWeaver	3214
@NP	1996 ; Krenz andWeaver	3237
@NP	1996	3237
@NP	Krenz andWeaver	3243
@NP	1998a	3260
@NP	All these changes	3268
@NP	an important role	3305
@NP	the pathophysiology	3326
@NP	autonomic dysreflexia	3349
@NP	an episodic disturbance	3372
@NP	autonomic functions , which may lead to serious consequences and death	3399
@NP	autonomic functions	3399
@NP	serious consequences and death	3438
@NP	It	3470
@NP	olfactory ensheathing cells -LRB- OECs -RRB-	3487
@NP	olfactory ensheathing cells	3487
@NP	OECs	3516
@NP	regeneration	3551
@NP	the injured spinal cord	3567
@NP	improved functional outcome	3614
@NP	SCI -LRB- Li et al. , 1998 ; Ramon-Cueto et al. , 2000 -RRB-	3652
@NP	SCI	3652
@NP	Li	3657
@NP	et al. , 1998 ; Ramon-Cueto et al. , 2000	3660
@NP	et al.	3660
@NP	1998 ; Ramon-Cueto et al.	3668
@NP	1998	3668
@NP	Ramon-Cueto et al.	3674
@NP	Ramon-Cueto	3674
@NP	et al.	3686
@NP	2000	3694
@NP	We	3701
@NP	transplantation of OECs	3720
@NP	transplantation	3720
@NP	OECs	3739
@NP	autonomic dysreflexia	3756
@NP	rats with T4 spinal cord transection	3781
@NP	rats	3781
@NP	T4 spinal cord transection	3791
@NP	alteration	3836
@NP	the morphology	3850
@NP	the SPNs adjacent to the injury -LRB- Kalincik et al. , 2010 -RRB-	3868
@NP	the SPNs	3868
@NP	the injury -LRB- Kalincik et al. , 2010 -RRB-	3889
@NP	the injury	3889
@NP	Kalincik	3901
@NP	et al. , 2010	3910
@NP	et al.	3910
@NP	2010	3918
@NP	the effects	3934
@NP	OECs on tissue injury	3949
@NP	OECs	3949
@NP	tissue injury	3957
@NP	cavitation and shrinkage	3980
@NP	primary afferent fibres	4026
@NP	high thoracic transection	4082
@NP	this study	4112
@NP	we	4123
@NP	formation of cavities and non-cavity tissue loss	4136
@NP	formation	4136
@NP	cavities and non-cavity tissue loss	4149
@NP	cavities	4149
@NP	non-cavity tissue loss	4162
@NP	primary afferent fibres within the dorsal horn	4199
@NP	primary afferent fibres	4199
@NP	the dorsal horn	4230
@NP	morphometric parameters	4250
@NP	SPNs in the spinal segments adjacent to a spinal cord transection	4277
@NP	SPNs	4277
@NP	the spinal segments adjacent to a spinal cord transection	4285
@NP	the spinal segments	4285
@NP	a spinal cord transection	4317
@NP	the level of T4	4346
@NP	the level	4346
@NP	T4	4359
@NP	we	4376
@NP	the effects of OEC transplantation	4388
@NP	the effects	4388
@NP	OEC transplantation	4403
@NP	these morphological features	4426
@NP	Materials and methods 2.1 .	4460
@NP	Materials and methods 2.1	4460
@NP	Materials	4460
@NP	methods 2.1	4474
@NP	Animals All experimental protocols and procedures	4487
@NP	Animals	4487
@NP	All experimental protocols and procedures	4495
@NP	the Animal Care and Ethics Committee	4554
@NP	the University of New South Wales in accordance	4594
@NP	the University	4594
@NP	New South Wales in accordance	4612
@NP	New South Wales	4612
@NP	accordance	4631
@NP	the guidelines of the National Health and Medical Research Council of Australia	4647
@NP	the guidelines of the National Health	4647
@NP	the guidelines	4647
@NP	the National Health	4665
@NP	Medical Research Council of Australia	4689
@NP	Medical Research Council	4689
@NP	Australia	4717
@NP	Experiments	4728
@NP	30 naive male Australian Albino Wistar rats	4758
@NP	Biological Resources Centre , University of New South Wales , Sydney , Australia	4803
@NP	Biological Resources Centre	4803
@NP	University of New South Wales	4832
@NP	University	4832
@NP	New South Wales	4846
@NP	Sydney , Australia	4863
@NP	11	4887
@NP	14 weeks	4891
@NP	350 -- 400 g.	4913
@NP	350	4913
@NP	400 g.	4917
@NP	The animals	4924
@NP	plastic home boxes -LRB- 65 × 40 × 22 cm -RRB-	4962
@NP	plastic home boxes	4962
@NP	65 × 40 × 22 cm	4982
@NP	65 × 40 ×	4982
@NP	65 ×	4982
@NP	40 ×	4985
@NP	22 cm	4988
@NP	ad-lib food and water	5015
@NP	a 12-h light/dark cycle	5055
@NP	2.2	5080
@NP	Cell preparation Cultures	5085
@NP	green fluorescent protein -LRB- GFP -RRB- - expressing OECs	5114
@NP	green fluorescent protein	5114
@NP	GFP	5141
@NP	OECs	5157
@NP	Kalincik et al. , 2010	5190
@NP	Kalincik	5190
@NP	et al.	5199
@NP	2010	5207
@NP	olfactory lamina propria	5223
@NP	Australian Albino Wistar male rats	5263
@NP	8 weeks of age	5299
@NP	8 weeks	5299
@NP	age	5310
@NP	0.25 % collagenase type IA	5334
@NP	0.25 %	5334
@NP	collagenase type IA	5340
@NP	neurotrophin 3 -LRB- 50 ng/ml -RRB-	5378
@NP	neurotrophin 3	5378
@NP	50 ng/ml	5394
@NP	survival of OECs in culture	5431
@NP	survival	5431
@NP	OECs in culture	5443
@NP	OECs	5443
@NP	culture	5451
@NP	their purity to close to 100 % -LRB- Bianco et al. , 2004 -RRB-	5472
@NP	100 % -LRB- Bianco et al. , 2004 -RRB-	5497
@NP	100 %	5497
@NP	Bianco	5503
@NP	et al. , 2004	5510
@NP	et al.	5510
@NP	2004	5518
@NP	90 % of cells	5530
@NP	90 %	5530
@NP	cells	5537
@NP	p75NFR	5567
@NP	1:200 , monoclonal ; Neubody , Thebarton , SA , Australia	5575
@NP	1:200	5575
@NP	monoclonal ; Neubody , Thebarton , SA , Australia	5582
@NP	monoclonal	5582
@NP	Neubody , Thebarton , SA , Australia	5594
@NP	fibrillary acidic protein	5639
@NP	1:250 , polyclonal GFAP ; Dako North America Inc. , CA , USA	5666
@NP	1:250	5666
@NP	polyclonal GFAP ; Dako North America Inc.	5673
@NP	polyclonal GFAP	5673
@NP	Dako North America Inc.	5690
@NP	CA , USA	5715
@NP	no cells	5731
@NP	HNK1 antibody -LRB- 1:200 ; Sigma Castle Hill , NSW , Australia -RRB-	5753
@NP	HNK1 antibody	5753
@NP	1:200 ; Sigma Castle Hill	5768
@NP	1:200	5768
@NP	Sigma Castle Hill	5775
@NP	NSW , Australia	5794
@NP	NSW	5794
@NP	Australia	5799
@NP	OECs	5811
@NP	humanised Renilla	5846
@NP	GFP	5875
@NP	pFB-hrGFP retroviral supernatant -LRB- Stratagene , La Jolla , CA , USA -RRB-	5885
@NP	pFB-hrGFP retroviral supernatant	5885
@NP	Stratagene	5919
@NP	La Jolla	5931
@NP	CA , USA	5941
@NP	a fluorescence-activated cell sorter -LRB- BD FACS Aria , BD Biosciences -RRB-	5966
@NP	a fluorescence-activated cell sorter	5966
@NP	BD FACS Aria , BD Biosciences	6004
@NP	BD FACS Aria	6004
@NP	BD Biosciences	6018
@NP	The viability and labelling of the modified OECs	6035
@NP	The viability and labelling	6035
@NP	the modified OECs	6066
@NP	the purpose of the present experiment	6102
@NP	the purpose	6102
@NP	the present experiment	6117
@NP	they	6144
@NP	GFP at least nine weeks	6182
@NP	GFP	6182
@NP	nine weeks	6195
@NP	injection	6212
@NP	rat spinal cord in other experiments in our laboratory -LRB- Dr.	6227
@NP	rat spinal cord	6227
@NP	other experiments in our laboratory -LRB- Dr.	6246
@NP	other experiments	6246
@NP	our laboratory -LRB- Dr.	6267
@NP	our laboratory	6267
@NP	Dr.	6283
@NP	Frank Cloutier , unpublished results -RRB- .	6287
@NP	Frank Cloutier	6287
@NP	results	6315
@NP	2.3	6325
@NP	T4	6330
@NP	spinal cord transection and OECs transplantation Transection	6333
@NP	the level of spinal segment T4	6397
@NP	the level	6397
@NP	spinal segment T4	6410
@NP	Kalincik et al. , 2010	6469
@NP	Kalincik	6469
@NP	et al.	6478
@NP	2010	6486
@NP	24 rats	6502
@NP	a mixture of ketamine hydrochloride -LRB- 100 mg / kg i.p.	6534
@NP	a mixture	6534
@NP	ketamine hydrochloride -LRB- 100 mg / kg	6547
@NP	ketamine hydrochloride	6547
@NP	100 mg	6571
@NP	kg	6579
@NP	Ketamine , Parnell Laboratories Pty.	6588
@NP	Ketamine	6588
@NP	Parnell Laboratories Pty.	6598
@NP	Ltd. , NSW , Australia -RRB- and xylazine -LRB- 7 mg/kg i.p.	6624
@NP	Ltd. , NSW , Australia -RRB-	6624
@NP	Ltd.	6624
@NP	NSW	6630
@NP	Australia	6635
@NP	xylazine -LRB- 7 mg/kg i.p.	6650
@NP	xylazine	6650
@NP	7 mg/kg i.p.	6660
@NP	7 mg/kg	6660
@NP	IliumXylazil-20 , Troy Laboratories Pty.	6674
@NP	IliumXylazil-20	6674
@NP	Troy Laboratories Pty.	6691
@NP	Ltd. , NSW , Australia -RRB- and the surgical site	6714
@NP	Ltd. , NSW , Australia -RRB-	6714
@NP	Ltd.	6714
@NP	NSW	6720
@NP	Australia	6725
@NP	the surgical site	6740
@NP	0.5 % bupivacaine hydrochloride -LRB- 0.1 ml ; bupivacaine , Pharmacia Pty.	6794
@NP	bupivacaine hydrochloride -LRB- 0.1 ml ; bupivacaine , Pharmacia Pty.	6799
@NP	bupivacaine hydrochloride	6799
@NP	0.1 ml ; bupivacaine , Pharmacia Pty.	6826
@NP	0.1 ml	6826
@NP	bupivacaine , Pharmacia Pty.	6834
@NP	bupivacaine	6834
@NP	Pharmacia Pty.	6847
@NP	Ltd. , WA , Australia -RRB- .	6862
@NP	Ltd. , WA , Australia -RRB-	6862
@NP	Ltd.	6862
@NP	WA , Australia -RRB-	6868
@NP	WA	6868
@NP	Laminectomy of the T3 vertebra	6884
@NP	Laminectomy	6884
@NP	the T3 vertebra	6899
@NP	the spinal cord	6935
@NP	microscissors at the level of T4	6982
@NP	microscissors	6982
@NP	the level of T4	6999
@NP	the level	6999
@NP	T4	7012
@NP	the OEC-treated animals -LRB- n = 12 -RRB-	7019
@NP	the OEC-treated animals	7019
@NP	n	7044
@NP	12	7046
@NP	the emergent gap between the spinal cord stumps -LRB- approx. 1 mm -RRB-	7051
@NP	the emergent gap	7051
@NP	the spinal cord stumps -LRB- approx. 1 mm -RRB-	7076
@NP	the spinal cord stumps	7076
@NP	1 mm	7108
@NP	sterile porcine gelatine sponge -LRB- approx. 2 × 1 × 1 mm ;	7130
@NP	sterile porcine gelatine sponge	7130
@NP	2 × 1 × 1 mm	7171
@NP	2 × 1 ×	7171
@NP	2 ×	7171
@NP	1 ×	7173
@NP	1 mm	7175
@NP	Gelfoam , Pharmacia & Upjohn Co.	7181
@NP	Kalamazoo , Mi , USA -RRB-	7213
@NP	Kalamazoo	7213
@NP	Mi	7224
@NP	USA	7228
@NP	2 μl of medium	7243
@NP	2 μl	7243
@NP	medium	7251
@NP	OECs -LRB- 500,000 cells/μl -RRB-	7269
@NP	OECs	7269
@NP	500,000 cells/μl	7275
@NP	the control animals -LRB- n = 12 -RRB-	7303
@NP	the control animals	7303
@NP	n	7324
@NP	12	7326
@NP	Gelfoam	7330
@NP	2 μl of culture medium	7348
@NP	2 μl	7348
@NP	culture medium	7356
@NP	Another Gelfoam block	7386
@NP	the dorsal surface of the spinal cord	7422
@NP	the dorsal surface	7422
@NP	the spinal cord	7444
@NP	the nervous tissue	7473
@NP	connective tissue	7509
@NP	the wound	7531
@NP	2.4	7553
@NP	Post-operative care Following surgery , the animals	7558
@NP	Post-operative care	7558
@NP	surgery , the animals	7588
@NP	surgery	7588
@NP	the animals	7597
@NP	27 °C	7622
@NP	Normotonic sodium chloride -LRB- 0.9 % , 5 -- 10 ml -RRB-	7629
@NP	Normotonic sodium chloride	7629
@NP	0.9 % , 5 -- 10 ml	7657
@NP	0.9 %	7657
@NP	5 -- 10 ml	7663
@NP	5	7663
@NP	10 ml	7665
@NP	cephalotin -LRB- 60 mg/kg , s.c. ; cephalotin sodium , VIC , Australia -RRB-	7676
@NP	cephalotin	7676
@NP	60 mg/kg , s.c. ; cephalotin sodium , VIC , Australia	7688
@NP	60 mg/kg	7688
@NP	s.c. ; cephalotin sodium	7698
@NP	s.c.	7698
@NP	cephalotin sodium	7704
@NP	VIC , Australia	7723
@NP	5 days	7788
@NP	Subcutaneous injections of the analgesic rimadyl -LRB- 5 mg/kg s.c. ;	7796
@NP	Subcutaneous injections	7796
@NP	the analgesic rimadyl -LRB- 5 mg/kg s.c. ;	7823
@NP	the analgesic rimadyl	7823
@NP	5 mg/kg s.c.	7846
@NP	Carprofen , Australia Pty.	7860
@NP	Carprofen	7860
@NP	Australia Pty.	7871
@NP	Ltd.	7886
@NP	Australia	7892
@NP	3 days	7930
@NP	The urinary bladderwas	7938
@NP	2	7980
@NP	3 times daily	7982
@NP	3 times	7982
@NP	autonomous bladder voidance reflexes gradually reestablished	8002
@NP	autonomous bladder voidance reflexes	8002
@NP	2 weeks	8075
@NP	Inspection for skin irritation , ulcers , and haematuria	8085
@NP	Inspection	8085
@NP	skin irritation , ulcers , and haematuria	8100
@NP	skin irritation	8100
@NP	ulcers	8117
@NP	haematuria	8129
@NP	animals were bathed and minor wounds treated	8170
@NP	animals were bathed	8170
@NP	animals	8170
@NP	minor wounds treated	8194
@NP	minor wounds	8194
@NP	2.5	8216
@NP	Tissue fixation and sectioning	8221
@NP	1 week -LRB- n = 12 -RRB- and 4 weeks -LRB- n = 12 -RRB- post-injury	8255
@NP	1 week -LRB- n = 12 -RRB-	8255
@NP	1 week	8255
@NP	n	8263
@NP	12	8265
@NP	4 weeks -LRB- n = 12 -RRB- post-injury	8273
@NP	4 weeks -LRB- n = 12 -RRB-	8273
@NP	n	8282
@NP	12	8284
@NP	post-injury	8288
@NP	the animals in both the OEC-treated and the control groups	8301
@NP	the animals	8301
@NP	both the OEC-treated and the control groups	8316
@NP	the OEC-treated	8321
@NP	the control groups	8341
@NP	pentobarbitone	8384
@NP	normotonic sodium chloride -LRB- 30 s -RRB-	8432
@NP	normotonic sodium chloride	8432
@NP	30 s	8460
@NP	4 % paraformaldehyde	8470
@NP	20 min ; Merck Schuchardt OHG	8491
@NP	20 min	8491
@NP	Merck Schuchardt OHG	8499
@NP	Hohenbrunn , Germany	8521
@NP	Hohenbrunn	8521
@NP	Germany	8533
@NP	addition	8546
@NP	6 intact rats	8556
@NP	the same procedure	8590
@NP	Spinal cord segments T1	8610
@NP	T7	8634
@NP	4 % paraformaldehyde -LRB- 2 h -RRB-	8666
@NP	4 % paraformaldehyde	8666
@NP	2 h	8687
@NP	30 % sucrose -LRB- 24 h -RRB-	8713
@NP	30 % sucrose	8713
@NP	24 h	8726
@NP	The segments T2	8733
@NP	T6	8749
@NP	a cryostat	8764
@NP	35 μm thick horizontal sections	8780
@NP	35 μm	8780
@NP	The sections	8813
@NP	gelatinised slides	8844
@NP	− 22 °C	8888
@NP	each animal	8900
@NP	three series	8913
@NP	NADPH-diaphorase	8943
@NP	two series	8961
@NP	hematoxylin-eosin	8990
@NP	one series	9009
@NP	GFP	9036
@NP	one series	9044
@NP	the examination of unlabelled GFP	9078
@NP	the examination	9078
@NP	unlabelled GFP	9097
@NP	Segments T1 and T7	9113
@NP	Segments T1	9113
@NP	T7	9129
@NP	a cryostat	9144
@NP	35 μm thick transverse sections	9160
@NP	35 μm	9160
@NP	calcitonin-gene related peptide -LRB- CGRP -RRB-	9208
@NP	calcitonin-gene related peptide	9208
@NP	CGRP	9241
@NP	2.6	9248
@NP	Histochemistry	9253
@NP	NADPH-diaphorase NADPH-diaphorase staining of sympathetic preganglionic neurons	9272
@NP	NADPH-diaphorase NADPH-diaphorase staining	9272
@NP	sympathetic preganglionic neurons	9318
@NP	a standard protocol -LRB- Carrive and Paxinos , 1994	9381
@NP	a standard protocol -LRB- Carrive and Paxinos	9381
@NP	a standard protocol	9381
@NP	Paxinos	9414
@NP	1994	9423
@NP	horizontal spinal cord sections	9439
@NP	phosphate buffered saline for 1 h	9486
@NP	phosphate buffered saline	9486
@NP	1 h	9516
@NP	0.05 % solution of NADPH -LRB- reduced NADPH , Sigma-Aldrich Pty.	9537
@NP	0.05 % solution	9537
@NP	NADPH -LRB- reduced NADPH , Sigma-Aldrich Pty.	9555
@NP	NADPH -LRB- reduced NADPH ,	9555
@NP	NADPH	9555
@NP	reduced NADPH	9562
@NP	reduced	9562
@NP	Pty.	9591
@NP	Ltd. , NSW , Australia -RRB- ,	9596
@NP	Ltd.	9596
@NP	NSW	9602
@NP	Australia	9607
@NP	0.0125 % nitroblue tetrazolium -LRB- Sigma Chemical Co. , MO , USA -RRB-	9619
@NP	0.0125 %	9619
@NP	nitroblue tetrazolium -LRB- Sigma Chemical Co. , MO , USA -RRB-	9627
@NP	nitroblue tetrazolium	9627
@NP	Sigma Chemical Co.	9650
@NP	MO	9670
@NP	USA	9674
@NP	0.5 % triton-X in phosphate buffer -LRB- pH = 7.4 -RRB-	9683
@NP	0.5 % triton-X	9683
@NP	phosphate buffer -LRB- pH = 7.4 -RRB-	9700
@NP	phosphate buffer	9700
@NP	pH	9718
@NP	7.4	9721
@NP	The tissue	9727
@NP	2 h at 37 °C	9762
@NP	2 h	9762
@NP	37 °C	9769
@NP	room temperature for 4 h.	9792
@NP	room temperature	9792
@NP	4 h.	9813
@NP	The reaction	9818
@NP	rinses in phosphate buffer and distilled water	9849
@NP	rinses	9849
@NP	phosphate buffer and distilled water	9859
@NP	phosphate buffer	9859
@NP	distilled water	9880
@NP	The sections	9897
@NP	overnight , cleared in 100 % ethanol for 4 -- 6 h ,	9925
@NP	overnight	9925
@NP	100 % ethanol for 4 -- 6 h	9947
@NP	100 % ethanol for 4	9947
@NP	100 % ethanol	9947
@NP	4	9964
@NP	6 h	9966
@NP	DAKO	9984
@NP	a light microscope -LRB- Olympus BX51 + DP70 -RRB-	10009
@NP	a light microscope	10009
@NP	Olympus BX51 + DP70	10029
@NP	Olympus BX51	10029
@NP	DP70	10042
@NP	2.7	10049
@NP	Immunohistochemistry CGRP	10054
@NP	a cyclic neuropeptide present in the primary afferent sensory neurons	10081
@NP	a cyclic neuropeptide	10081
@NP	the primary afferent sensory neurons	10114
@NP	a polyclonal rabbit	10170
@NP	anti-rat CGRP primary antibody	10190
@NP	1:10,000	10222
@NP	C8198 , Sigma-Aldrich , MI , USA	10232
@NP	C8198	10232
@NP	Sigma-Aldrich	10239
@NP	MI	10254
@NP	USA	10258
@NP	synthetic rat CGRP	10291
@NP	No cross-reactivity with other rodent proteins	10311
@NP	No cross-reactivity	10311
@NP	other rodent proteins	10336
@NP	Brejot et al. , 2006	10378
@NP	Brejot	10378
@NP	et al.	10385
@NP	2006	10393
@NP	GFP	10400
@NP	a polyclonal rabbit antibody	10422
@NP	1:300 , 240142 , Stratagene , La Jolla CA , USA	10452
@NP	1:300	10452
@NP	240142	10459
@NP	Stratagene	10467
@NP	La Jolla CA	10479
@NP	USA	10492
@NP	full-length humanised R. reniformis GFP purified from E. coli	10525
@NP	full-length humanised R. reniformis GFP	10525
@NP	E. coli	10579
@NP	No cross-reactivity with rodent proteins	10588
@NP	No cross-reactivity	10588
@NP	rodent proteins	10613
@NP	Han et al. , 2006	10648
@NP	Han	10648
@NP	et al.	10652
@NP	2006	10660
@NP	the tissue sections	10676
@NP	xylene and 100 % ethanol	10712
@NP	xylene	10712
@NP	100 % ethanol	10723
@NP	normotonic phosphate	10763
@NP	saline -LRB- pH = 7.4 -RRB-	10793
@NP	saline	10793
@NP	pH	10801
@NP	7.4	10804
@NP	0.3 % Triton-X	10820
@NP	Chem Supply	10835
@NP	SA	10848
@NP	Australia	10852
@NP	a 30 min preincubationwith phosphate	10870
@NP	saline-Triton-X solution	10916
@NP	10 %	10952
@NP	goat serum	10956
@NP	the sectionswere incubatedwith the primary antibody for 24 h at 4 °C	10968
@NP	the sectionswere incubatedwith	10968
@NP	the primary antibody for 24 h at 4 °C	10999
@NP	the primary antibody	10999
@NP	24 h at 4 °C	11024
@NP	24 h	11024
@NP	4 °C	11032
@NP	The sections	11038
@NP	phosphate	11071
@NP	saline	11090
@NP	Alexa Fluor 488-conjugated goat anti-rabbit	11116
@NP	1:500	11161
@NP	A11070 , Molecular Probes , Oregon , USA	11168
@NP	A11070	11168
@NP	Molecular Probes	11176
@NP	Oregon	11194
@NP	USA	11202
@NP	TRITC-conjugated goat	11210
@NP	anti-rabbit secondary antibody -LRB- 1:200 ; R0156 , Dako , Denmark -RRB-	11232
@NP	anti-rabbit secondary antibody	11232
@NP	1:200 ; R0156	11264
@NP	1:200	11264
@NP	R0156	11271
@NP	Dako , Denmark	11278
@NP	Dako	11278
@NP	Denmark	11284
@NP	2 h at roomtemperature	11297
@NP	2 h	11297
@NP	roomtemperature	11304
@NP	the sectionswere counterstainedwith	11330
@NP	bisbenzimide -LRB- 0.001 % , Hoechst 33258 , Invitrogen Pty.	11366
@NP	bisbenzimide	11366
@NP	0.001 %	11380
@NP	Hoechst 33258	11388
@NP	Invitrogen Pty.	11403
@NP	Ltd. , VIC , Australia -RRB- for 20 min	11419
@NP	Ltd. , VIC , Australia -RRB-	11419
@NP	Ltd.	11419
@NP	VIC	11425
@NP	Australia	11430
@NP	20 min	11445
@NP	DAKO mounting medium	11477
@NP	DakoCytomation	11499
@NP	Dako North America Inc.	11515
@NP	CA , USA	11540
@NP	No positive labelling	11550
@NP	the antibodies	11586
@NP	rat liver	11620
@NP	spleen tissue -LRB- CGRP antibody specificity tests -RRB-	11634
@NP	spleen tissue	11634
@NP	CGRP antibody specificity tests	11649
@NP	normal spinal cord -LRB- GFP antibody specificity tests -RRB-	11683
@NP	normal spinal cord	11683
@NP	GFP antibody specificity tests	11703
@NP	unlabelled spinal cord tissue -LRB- secondary antibody specificity tests -RRB-	11738
@NP	unlabelled spinal cord tissue	11738
@NP	secondary antibody specificity tests	11769
@NP	The tissue	11808
@NP	a fluorescent microscope -LRB- Olympus BX51 + DP70 -RRB-	11839
@NP	a fluorescent microscope	11839
@NP	Olympus BX51 + DP70	11865
@NP	Olympus BX51	11865
@NP	DP70	11878
@NP	2.8	11885
@NP	Quantification of the injury size	11890
@NP	Quantification	11890
@NP	the injury size	11908
@NP	The extent	11924
@NP	cavity and non-cavity tissue loss	11938
@NP	rostral and caudal	11972
@NP	the transection	11994
@NP	the previously published protocol -LRB- Potas et al. , 2006 -RRB-	12036
@NP	the previously published protocol	12036
@NP	Potas	12071
@NP	et al. , 2006	12077
@NP	et al.	12077
@NP	2006	12085
@NP	ImageJ software	12101
@NP	Wayne Rasband , National Institutes of Health , USA	12118
@NP	Wayne Rasband	12118
@NP	National Institutes of Health	12133
@NP	National Institutes	12133
@NP	Health	12156
@NP	USA	12164
@NP	each animal	12173
@NP	two horizontal sections stained with hematoxylin-eosin	12186
@NP	two horizontal sections	12186
@NP	hematoxylin-eosin	12223
@NP	one ventral and one dorsal to the central canal -LRB- 0.5 -- 1 mm apart -RRB-	12242
@NP	one ventral and one dorsal	12242
@NP	one	12242
@NP	one	12258
@NP	the central canal -LRB- 0.5 -- 1 mm apart -RRB-	12272
@NP	the central canal	12272
@NP	0.5 -- 1 mm apart	12291
@NP	0.5	12291
@NP	1 mm apart	12295
@NP	The rostral area of interest	12323
@NP	The rostral area	12323
@NP	interest	12343
@NP	a line	12372
@NP	the rostral border	12388
@NP	the intact tissue and the fibrotic scar	12415
@NP	the intact tissue	12415
@NP	the fibrotic scar	12437
@NP	Fig. 1	12456
@NP	line x	12464
@NP	a parallel line 2 mm further rostral -LRB- Fig. 1 , line y -RRB-	12473
@NP	a parallel line	12473
@NP	2 mm	12489
@NP	Fig. 1	12511
@NP	line y	12519
@NP	two longitudinal lines	12537
@NP	the lateral edges of the horizontal section	12578
@NP	the lateral edges	12578
@NP	the horizontal section	12599
@NP	y	12625
@NP	a similar approach	12652
@NP	the area of interest caudal to the lesion	12672
@NP	the area	12672
@NP	interest caudal to the lesion	12684
@NP	interest caudal	12684
@NP	the lesion	12703
@NP	Fig. 1 , lines w and z	12727
@NP	Fig. 1	12727
@NP	lines w and z	12735
@NP	lines	12735
@NP	w and z	12741
@NP	w and	12741
@NP	w	12741
@NP	Injury within these rostral and caudal areas	12751
@NP	Injury	12751
@NP	these rostral and caudal areas	12765
@NP	these rostral	12765
@NP	caudal areas	12783
@NP	cavity tissue loss	12818
@NP	tissue	12849
@NP	loss completely bordered by spinal cord tissue	12856
@NP	loss	12856
@NP	spinal cord tissue	12884
@NP	ii	12909
@NP	non-cavity tissue loss	12913
@NP	fibrosis or shrinkage of the cord edges	12948
@NP	fibrosis or shrinkage	12948
@NP	the cord edges	12973
@NP	both instances	12992
@NP	the extent of injury	13008
@NP	the extent	13008
@NP	injury	13022
@NP	the average	13033
@NP	the measurements	13048
@NP	the 2 horizontal sections per animal	13068
@NP	the 2 horizontal sections	13068
@NP	animal	13098
@NP	a percentage of the total rostral or caudal area of interest	13119
@NP	a percentage of the total rostral	13119
@NP	a percentage	13119
@NP	the total rostral	13135
@NP	caudal area of interest	13156
@NP	caudal area	13156
@NP	interest	13171
@NP	2.9	13181
@NP	Morphometric analysis of sympathetic preganglionic neurons	13186
@NP	Morphometric analysis	13186
@NP	sympathetic preganglionic neurons	13211
@NP	Morphological features	13245
@NP	sympathetic preganglionic neurons in the injured and intact spinal cords	13271
@NP	sympathetic preganglionic neurons	13271
@NP	the injured and intact spinal cords	13308
@NP	Kalincik et al. , 2010	13383
@NP	Kalincik	13383
@NP	et al.	13392
@NP	2010	13400
@NP	each animal , 2	13410
@NP	each animal	13410
@NP	2	13423
@NP	3 horizontal sections through the intermediolateral column	13425
@NP	3 horizontal sections	13425
@NP	the intermediolateral column	13455
@NP	and 9 -- 10 neurons located rostral -LRB- T2 -- T3 -RRB- and 9	13498
@NP	and 9	13498
@NP	10 neurons located rostral -LRB- T2 -- T3 -RRB- and 9	13505
@NP	10 neurons located rostral -LRB- T2 -- T3 -RRB-	13505
@NP	10 neurons located rostral	13505
@NP	10 neurons	13505
@NP	T2 -- T3	13533
@NP	T2	13533
@NP	T3	13536
@NP	9	13544
@NP	10 neurons located caudal -LRB- T5 -- T6 -RRB- to the injury	13546
@NP	10 neurons located caudal -LRB- T5 -- T6 -RRB-	13546
@NP	10 neurons located caudal	13546
@NP	10 neurons	13546
@NP	T5 -- T6	13573
@NP	T5	13573
@NP	T6	13576
@NP	the injury	13583
@NP	ImageJ software	13614
@NP	The morphometric features of each cell	13631
@NP	The morphometric features	13631
@NP	each cell	13660
@NP	one 35 μm thick horizontal section	13691
@NP	one 35 μm	13691
@NP	Only cells with clearly distinguishable perikarya and dendritic trees	13727
@NP	Only cells	13727
@NP	clearly distinguishable perikarya and dendritic trees	13743
@NP	clearly distinguishable perikarya	13743
@NP	dendritic trees	13781
@NP	The examined neurons	13812
@NP	the criteria	13843
@NP	the nucleus intermediolateralis pars principalis and pars funicularis	13872
@NP	2 segments	13959
@NP	the injury site	13975
@NP	both left and right intermediolateral columns -LRB- Fig. 2 -RRB-	14022
@NP	both left and right intermediolateral columns	14022
@NP	Fig. 2	14069
@NP	Three morphological features were recorded	14078
@NP	Three morphological features	14078
@NP	-LRB- i -RRB- cross-sectional area	14122
@NP	i	14123
@NP	soma	14150
@NP	-LRB- ii -RRB- overall length of all visible processes	14156
@NP	-LRB- ii -RRB- overall length	14156
@NP	ii	14157
@NP	all visible processes	14179
@NP	iii	14206
@NP	number of primary dendrites	14211
@NP	number	14211
@NP	primary dendrites	14221
@NP	The morphological features	14240
@NP	OEC-treated , control and intact animals	14289
@NP	control	14302
@NP	2.10	14330
@NP	Quantification	14336
@NP	the primary afferent fibre density	14354
@NP	The analysis of the density of primary afferent fibres	14389
@NP	The analysis	14389
@NP	the density of primary afferent fibres	14405
@NP	the density	14405
@NP	primary afferent fibres	14420
@NP	CGRP	14456
@NP	transverse sections	14478
@NP	T1 and T7	14503
@NP	ImageJ software	14519
@NP	laminae	14542
@NP	the help of the atlas of rat	14571
@NP	the help	14571
@NP	the atlas of rat	14583
@NP	the atlas	14583
@NP	rat	14596
@NP	spinal cord anatomy -LRB- Watson et al. , 2008 -RRB-	14600
@NP	spinal cord anatomy	14600
@NP	Watson	14621
@NP	et al. , 2008	14628
@NP	et al.	14628
@NP	2008	14636
@NP	Signal intensity of the background from each of the CGRP immunoreacted sections	14643
@NP	Signal intensity	14643
@NP	the background from each of the CGRP immunoreacted sections	14663
@NP	the background	14663
@NP	each of the CGRP immunoreacted sections	14683
@NP	each	14683
@NP	the CGRP immunoreacted sections	14691
@NP	a 10,000 μm2 square selection	14743
@NP	the lamina VII	14776
@NP	This	14792
@NP	each image	14817
@NP	the images	14832
@NP	uniform criteria -LRB- Fig. 3 -RRB-	14871
@NP	uniform criteria	14871
@NP	Fig. 3	14889
@NP	A grid with circular selections -LRB- area : 1000 μm2 each -RRB-	14898
@NP	A grid with circular selections	14898
@NP	A grid	14898
@NP	circular selections	14910
@NP	area : 1000 μm2 each	14931
@NP	area	14931
@NP	1000 μm2 each	14937
@NP	1000 μm2	14937
@NP	each	14946
@NP	laminae I -- V ,	14974
@NP	laminae I	14974
@NP	laminae	14974
@NP	I	14982
@NP	V	14984
@NP	5 selections per lamina	14994
@NP	5 selections	14994
@NP	lamina	15011
@NP	The percentage of CGRP positivity within each of the five areas per lamina	15019
@NP	The percentage	15019
@NP	CGRP positivity within each of the five areas per lamina	15037
@NP	CGRP positivity	15037
@NP	each of the five areas per lamina	15060
@NP	each	15060
@NP	the five areas per lamina	15068
@NP	the five areas	15068
@NP	lamina	15087
@NP	The measurements	15108
@NP	lamina and animal	15143
@NP	2.11	15162
@NP	Data	15168
@NP	9 weeks	15176
@NP	post-injury	15184
@NP	addition to the experiments	15199
@NP	addition	15199
@NP	the experiments	15211
@NP	the intact animals	15242
@NP	n	15262
@NP	6	15264
@NP	those with SCI -LRB- n = 24 -RRB- included in this study	15271
@NP	those	15271
@NP	SCI -LRB- n = 24 -RRB- included in this study	15282
@NP	SCI	15282
@NP	n	15287
@NP	24	15289
@NP	this study	15305
@NP	1 and 4 weeks	15317
@NP	data	15345
@NP	the extent of cavity and noncavity tissue loss	15361
@NP	the extent	15361
@NP	cavity and noncavity tissue loss	15375
@NP	the morphometric features of SPNs from our previous experiments	15412
@NP	the morphometric features	15412
@NP	SPNs from our previous experiments	15441
@NP	SPNs	15441
@NP	our previous experiments	15451
@NP	9 weeks	15479
@NP	the present manuscript -LRB- Kalincik et al. , 2010 -RRB-	15521
@NP	the present manuscript	15521
@NP	Kalincik	15545
@NP	et al. , 2010	15554
@NP	et al.	15554
@NP	2010	15562
@NP	This	15569
@NP	order	15586
@NP	a comparison of the early changes	15601
@NP	a comparison	15601
@NP	the early changes	15617
@NP	those seen at longer survival times	15640
@NP	those	15640
@NP	longer survival times	15654
@NP	The animals from the previous study -LRB- n = 13 -RRB-	15677
@NP	The animals	15677
@NP	the previous study -LRB- n = 13 -RRB-	15694
@NP	the previous study	15694
@NP	n	15714
@NP	13	15716
@NP	the same surgeon	15737
@NP	protocols identical to those used here	15763
@NP	protocols	15763
@NP	those used here	15786
@NP	those	15786
@NP	The data describing the morphometric features of SPNs	15803
@NP	The data	15803
@NP	the morphometric features of SPNs	15823
@NP	the morphometric features	15823
@NP	SPNs	15852
@NP	the data describing the injury size at 9 weeks post-injury	15895
@NP	the data	15895
@NP	the injury size	15915
@NP	9 weeks	15934
@NP	Quantification of the primary afferent fibre density	15965
@NP	Quantification	15965
@NP	the primary afferent fibre density	15983
@NP	animals at 9 weeks post	16041
@NP	animals	16041
@NP	9 weeks post	16052
@NP	SCI , as segments T1 and T7 were not collected	16066
@NP	SCI	16066
@NP	segments T1 and T7	16074
@NP	segments T1	16074
@NP	T7	16090
@NP	2.12	16113
@NP	Statistical analysis All measurements were carried out by a researcher	16119
@NP	Statistical analysis	16119
@NP	All measurements	16140
@NP	a researcher	16177
@NP	the treatment	16201
@NP	Data	16216
@NP	mean ± SEM	16249
@NP	Software package SPSS 17.0 for Windows -LRB- SPSS Inc. , Illinois , USA -RRB-	16259
@NP	Software package SPSS 17.0 for Windows	16259
@NP	Software package SPSS	16259
@NP	17.0 for Windows	16281
@NP	17.0	16281
@NP	Windows	16290
@NP	SPSS Inc.	16299
@NP	Illinois	16310
@NP	USA	16320
@NP	all statistical analyses	16338
@NP	Effects	16364
@NP	p	16403
@NP	≤ 0.05	16404
@NP	A three-way analysis of variance -LRB- ANOVA -RRB-	16411
@NP	A three-way analysis of variance	16411
@NP	A three-way analysis	16411
@NP	variance	16435
@NP	ANOVA	16445
@NP	cavity tissue loss , non-cavity tissue loss and CGRP density	16472
@NP	cavity tissue loss	16472
@NP	non-cavity tissue loss	16492
@NP	CGRP density	16519
@NP	the selected laminae	16535
@NP	respect	16561
@NP	Treatment -LRB- OEC-treated vs. control groups -RRB-	16572
@NP	Treatment	16572
@NP	OEC-treated vs. control groups	16583
@NP	OEC-treated	16583
@NP	control groups	16599
@NP	Position -LRB- rostral vs. caudal to the SCI -RRB-	16616
@NP	Position	16616
@NP	rostral vs. caudal to the SCI	16626
@NP	rostral	16626
@NP	caudal to the SCI	16638
@NP	caudal	16638
@NP	the SCI	16648
@NP	Time	16661
@NP	the cord transection	16676
@NP	intact vs. week	16698
@NP	1 vs. week 4 vs. week 9 post-injury	16714
@NP	1	16714
@NP	week 4 vs. week	16720
@NP	week 4	16720
@NP	week	16731
@NP	Cavity and non-cavity tissue loss	16752
@NP	week 9 post-SCI in the OECtreated vs. control rats	16789
@NP	week 9 post-SCI	16789
@NP	the OECtreated vs. control rats	16808
@NP	rostral vs. caudal to the lesion	16844
@NP	rostral	16844
@NP	caudal to the lesion	16856
@NP	caudal	16856
@NP	the lesion	16866
@NP	a two-way ANOVA	16896
@NP	Linear association between cavity tissue loss and non-cavity tissue loss	16913
@NP	Linear association	16913
@NP	cavity tissue loss and non-cavity tissue loss	16940
@NP	cavity tissue loss	16940
@NP	non-cavity tissue loss	16963
@NP	a linear regression analysis	17004
@NP	Comparison	17034
@NP	morphometric features	17048
@NP	the SPNs with respect to Treatment , Position and Time post-injury	17073
@NP	the SPNs	17073
@NP	respect to Treatment , Position and Time post-injury	17087
@NP	respect	17087
@NP	Treatment , Position and Time post-injury	17098
@NP	Treatment	17098
@NP	Position	17109
@NP	Time post-injury	17122
@NP	Time	17122
@NP	post-injury	17127
@NP	a linear mixed model -LRB- MIXED , SPSS 17.0 -RRB-	17160
@NP	a linear mixed model	17160
@NP	MIXED	17182
@NP	SPSS 17.0	17189
@NP	restricted maximum likelihood algorithm	17207
@NP	fixed and random effects -LRB- Kalincik et al. , 2010 -RRB-	17259
@NP	fixed and random effects	17259
@NP	Kalincik	17285
@NP	et al. , 2010	17294
@NP	et al.	17294
@NP	2010	17302
@NP	The effects of Treatment , Position and Time post-injury	17309
@NP	The effects	17309
@NP	Treatment , Position and Time post-injury	17324
@NP	Treatment	17324
@NP	Position	17335
@NP	Time post-injury	17348
@NP	Time	17348
@NP	post-injury	17353
@NP	the subject effect	17391
@NP	The model	17433
@NP	full factorial interaction terms	17465
@NP	residual terms -LRB- global and subject -RRB-	17502
@NP	residual terms	17502
@NP	Constant correlation	17539
@NP	all pairs of measurements on the same animal	17576
@NP	all pairs	17576
@NP	measurements on the same animal	17589
@NP	measurements	17589
@NP	the same animal	17605
@NP	all analyses	17625
@NP	post-hoc comparisons	17639
@NP	Tukey 's tests -LRB- effect of Time post-injury -RRB-	17682
@NP	Tukey 's tests	17682
@NP	Tukey 's	17682
@NP	effect of Time post-injury	17697
@NP	effect	17697
@NP	Time post-injury	17707
@NP	unpaired t-tests -LRB- Position and Treatment effects -RRB-	17729
@NP	unpaired t-tests	17729
@NP	Position and Treatment effects	17747
@NP	Position	17747
@NP	Treatment effects	17760
@NP	Results Fig. 1 .	17784
@NP	Results	17784
@NP	Fig. 1	17792
@NP	Longitudinal section	17800
@NP	the T4 transection with an illustration of the areas of interest	17829
@NP	the T4 transection	17829
@NP	an illustration of the areas of interest	17853
@NP	an illustration	17853
@NP	the areas of interest	17872
@NP	the areas	17872
@NP	interest	17885
@NP	the purpose of measurement	17898
@NP	the purpose	17898
@NP	measurement	17913
@NP	cavity tissue loss -LRB- C -RRB- and non-cavity tissue loss -LRB- NC -RRB-	17928
@NP	cavity tissue loss	17928
@NP	C	17948
@NP	non-cavity tissue loss	17955
@NP	NC	17979
@NP	The areas of interest	17984
@NP	The areas	17984
@NP	interest	17997
@NP	the lines	18025
@NP	the border	18044
@NP	the intact tissue and the fibrotic scar -LRB- x , rostral ; w , caudal -RRB-	18063
@NP	the intact tissue	18063
@NP	the fibrotic scar -LRB- x , rostral ; w , caudal -RRB-	18085
@NP	the fibrotic scar	18085
@NP	x , rostral ; w , caudal	18104
@NP	x	18104
@NP	rostral ; w	18107
@NP	rostral	18107
@NP	w	18116
@NP	caudal	18119
@NP	the parallel	18134
@NP	2 mm rostrally -LRB- y -RRB-	18159
@NP	2 mm rostrally	18159
@NP	2 mm	18159
@NP	y	18175
@NP	the previous lines	18197
@NP	Lateral borders of the areas	18217
@NP	Lateral borders	18217
@NP	the areas	18236
@NP	parallel lines	18262
@NP	the lateral edges of lines y or z	18288
@NP	the lateral edges of lines y or	18288
@NP	lines y	18309
@NP	the lesion	18344
@NP	lines x or w.	18363
@NP	lines x or	18363
@NP	lines x	18363
@NP	lines	18363
@NP	x	18369
@NP	Fig. 2 .	18378
@NP	Fig.	18378
@NP	2	18383
@NP	Examples	18386
@NP	sympathetic preganglionic neurons and their measured morphometric features	18398
@NP	sympathetic preganglionic neurons	18398
@NP	their measured morphometric features	18436
@NP	A , longitudinal section through an injured spinal cord	18474
@NP	, longitudinal section through an injured spinal cord	18475
@NP	, longitudinal section	18475
@NP	an injured spinal cord	18506
@NP	NADPHdiaphorase	18541
@NP	Sympathetic preganglionic neurons	18558
@NP	the intermediolateral columns -LRB- IML , arrowheads -RRB-	18595
@NP	the intermediolateral columns	18595
@NP	IML	18626
@NP	arrowheads	18631
@NP	the lateral aspects of the grey matter rostral and Fig. 3	18659
@NP	the lateral aspects	18659
@NP	the grey matter rostral and Fig. 3	18682
@NP	the grey matter rostral	18682
@NP	Fig. 3	18711
@NP	Example of the CGRP density measurement .	18719
@NP	Example	18719
@NP	the CGRP density measurement	18730
@NP	Background signal intensity	18760
@NP	Rexed lamina VII	18800
@NP	white squares	18818
@NP	the image	18853
@NP	the area of the CGRP positivity	18867
@NP	the area	18867
@NP	the CGRP positivity	18879
@NP	5 selections	18915
@NP	lamina -LRB- circles -RRB- superimposed as a grid over the section	18932
@NP	lamina	18932
@NP	circles	18940
@NP	a grid over the section	18965
@NP	a grid	18965
@NP	the section	18977
@NP	Laminae I -- V were assessed .	18990
@NP	Laminae I	18990
@NP	Laminae	18990
@NP	I	18998
@NP	V were assessed	19000
@NP	V	19000
@NP	I	19017
@NP	VII , Rexed laminae	19019
@NP	VII	19019
@NP	Rexed laminae	19024
@NP	CC , central canal	19039
@NP	CC	19039
@NP	central canal	19043
@NP	D , dorsal nucleus	19058
@NP	D	19058
@NP	dorsal nucleus	19061
@NP	ICL , intercalated nucleus	19077
@NP	ICL	19077
@NP	intercalated nucleus	19082
@NP	IML , intermediolateral nucleus	19104
@NP	IML	19104
@NP	intermediolateral nucleus	19109
@NP	IMM , intermediomedial nucleus	19136
@NP	IMM	19136
@NP	intermediomedial nucleus	19141
@NP	Fig. 4 .	19168
@NP	Fig.	19168
@NP	4	19173
@NP	Cavity and non-cavity tissue loss .	19176
@NP	Cavity and non-cavity tissue	19176
@NP	loss	19205
@NP	Increase in the extent of cavity tissue loss with Time post-injury	19211
@NP	Increase	19211
@NP	the extent of cavity tissue loss with Time post-injury	19223
@NP	the extent	19223
@NP	cavity tissue loss with Time post-injury	19237
@NP	cavity tissue loss	19237
@NP	Time post-injury	19261
@NP	apparent rostral and caudal	19282
@NP	the transection in both groups -LRB- pb0 .001 , three-way ANOVA -RRB-	19313
@NP	the transection	19313
@NP	both groups -LRB- pb0 .001 , three-way ANOVA -RRB-	19332
@NP	both groups	19332
@NP	pb0 .001 , three-way ANOVA	19345
@NP	pb0 .001	19345
@NP	three-way ANOVA	19354
@NP	The effect of Treatment	19372
@NP	The effect	19372
@NP	Treatment	19386
@NP	week 9 when analysed separately -LRB- p = 0.05 , two-way ANOVA -RRB-	19412
@NP	week 9	19412
@NP	p = 0.05 , two-way ANOVA	19445
@NP	p = 0.05	19445
@NP	p	19445
@NP	0.05	19447
@NP	two-way ANOVA	19453
@NP	≤	19473
@NP	0.05 -LRB- vs. week 1 -RRB- ; † , p ≤ 0.05 -LRB- vs. week 4 -RRB-	19474
@NP	0.05	19474
@NP	week 1	19484
@NP	† , p ≤ 0.05 -LRB- vs. week 4 -RRB-	19493
@NP	†	19493
@NP	p ≤ 0.05 -LRB- vs. week 4 -RRB-	19496
@NP	p	19496
@NP	≤ 0.05 -LRB- vs. week 4 -RRB-	19497
@NP	≤ 0.05	19497
@NP	week 4	19508
@NP	Tukey test -LRB- post-hoc -RRB-	19517
@NP	Tukey test	19517
@NP	Fig. 5 .	19541
@NP	Fig.	19541
@NP	5	19546
@NP	Morphometric features of the SPNs at segments T2	19549
@NP	Morphometric features	19549
@NP	the SPNs at segments T2	19574
@NP	the SPNs	19574
@NP	segments T2	19586
@NP	3 and T5	19598
@NP	3	19598
@NP	T5	19604
@NP	6	19607
@NP	the intact rats -LRB- int -RRB-	19612
@NP	the intact rats	19612
@NP	int	19629
@NP	the rats	19641
@NP	1 week -LRB- w1 -RRB- , 4 weeks -LRB- w4 -RRB- and 9 weeks -LRB- w9 -RRB-	19653
@NP	1 week -LRB- w1 -RRB-	19653
@NP	1 week	19653
@NP	w1	19661
@NP	4 weeks -LRB- w4 -RRB-	19666
@NP	w4	19675
@NP	9 weeks -LRB- w9 -RRB-	19683
@NP	w9	19692
@NP	post-injury	19696
@NP	Significant interactions between Position -LRB- T2 -- 3 , T5 -- 6 -RRB-	19709
@NP	Significant interactions	19709
@NP	Position -LRB- T2 -- 3 , T5 -- 6 -RRB-	19742
@NP	Position	19742
@NP	T2 -- 3	19752
@NP	T2	19752
@NP	3	19755
@NP	T5 -- 6	19758
@NP	T5	19758
@NP	6	19761
@NP	Treatment -LRB- control , OECtreated -RRB-	19765
@NP	Treatment	19765
@NP	control , OECtreated	19776
@NP	control	19776
@NP	Time post-injury -LRB- int , w1 , w4 and w9 -RRB-	19801
@NP	Time	19801
@NP	post-injury -LRB- int , w1 , w4 and w9 -RRB-	19806
@NP	post-injury	19806
@NP	int , w1 , w4 and w9	19819
@NP	int	19819
@NP	w1 , w4 and w9	19824
@NP	all three analysed features -LRB- pb0 .03 , linear mixed model -RRB-	19853
@NP	all three analysed features	19853
@NP	pb0 .03	19882
@NP	linear mixed model	19890
@NP	Treatment , p ≤ 0.05 , t-test -LRB- post-hoc -RRB-	19924
@NP	Treatment , p ≤ 0.05 ,	19924
@NP	Treatment	19924
@NP	p ≤ 0.05	19935
@NP	p	19935
@NP	≤ 0.05	19936
@NP	Fig. 6 .	19963
@NP	Fig.	19963
@NP	6	19968
@NP	Density of the CGRP-labelled primary afferent fibres within laminae I	19971
@NP	Density of the CGRP-labelled primary afferent fibres within laminae	19971
@NP	Density	19971
@NP	the CGRP-labelled primary afferent fibres within laminae	19982
@NP	the CGRP-labelled primary afferent fibres	19982
@NP	laminae	20031
@NP	I	20039
@NP	V of the dorsal horns at T1 and T7	20041
@NP	V	20041
@NP	the dorsal horns at T1 and T7	20046
@NP	the dorsal horns	20046
@NP	T1 and T7	20066
@NP	A significant effect of Time post-injury	20077
@NP	A significant effect	20077
@NP	Time post-injury	20101
@NP	lamina II -LRB- p = 0.04 , three-way ANOVA -RRB-	20131
@NP	lamina II	20131
@NP	p = 0.04 , three-way ANOVA	20142
@NP	p = 0.04	20142
@NP	p	20142
@NP	0.04	20144
@NP	three-way ANOVA	20150
@NP	* , p ≤ 0.05 -LRB- vs. week 1 -RRB- , Tukey 's test -LRB- post-hoc -RRB- .	20168
@NP	*	20168
@NP	p ≤ 0.05 -LRB- vs. week 1 -RRB-	20171
@NP	p	20171
@NP	≤ 0.05 -LRB- vs. week 1 -RRB-	20172
@NP	≤ 0.05	20172
@NP	week 1	20183
@NP	Tukey 's test -LRB- post-hoc -RRB-	20192
@NP	Tukey 's test	20192
@NP	Tukey 's	20192
@NP	our lab	20244
@NP	OECs transplanted into the transection site within a Gelfoam block	20253
@NP	OECs	20253
@NP	the transection site	20276
@NP	a Gelfoam block	20304
@NP	the transplant	20341
@NP	week 1	20359
@NP	4 weeks post-injury -LRB- Kalincik et al. , 2010 -RRB-	20390
@NP	4 weeks post-injury	20390
@NP	Kalincik	20411
@NP	et al. , 2010	20420
@NP	et al.	20420
@NP	2010	20428
@NP	3.1	20435
@NP	Injury size	20440
@NP	the T4 transection	20462
@NP	we	20482
@NP	a formation of intraspinal cavities and an overall decrease	20494
@NP	a formation	20494
@NP	intraspinal cavities and an overall decrease	20509
@NP	intraspinal cavities	20509
@NP	an overall decrease	20534
@NP	the volume	20557
@NP	the nervous tissue	20571
@NP	both rostral and caudal stumps	20593
@NP	rostral	20598
@NP	caudal stumps	20610
@NP	the injured spinal cord -LRB- Fig. 1 -RRB-	20627
@NP	the injured spinal cord	20627
@NP	Fig. 1	20652
@NP	It	20661
@NP	Fig. 4	20681
@NP	the extent of cavities in both OEC and control groups	20693
@NP	the extent	20693
@NP	cavities in both OEC and control groups	20707
@NP	cavities	20707
@NP	both OEC and control groups	20719
@NP	OEC	20724
@NP	control groups	20732
@NP	time postinjury	20772
@NP	the segments rostral and caudal	20791
@NP	the SCI	20826
@NP	Cavities	20835
@NP	only about 5 % of the rostral and caudal stumps	20853
@NP	only about 5 %	20853
@NP	the rostral and caudal stumps	20870
@NP	the rostral	20870
@NP	caudal stumps	20886
@NP	week 1	20903
@NP	10 % by week 4	20925
@NP	10 %	20925
@NP	week 4	20932
@NP	over 20 %	20946
@NP	week 9	20958
@NP	This increase	20966
@NP	the level	20988
@NP	statistical significance -LRB- pb0 .001 , F2 ,34 = 23.3 , three-way ANOVA -RRB-	21001
@NP	statistical significance	21001
@NP	pb0 .001 , F2 ,34 = 23.3 , three-way ANOVA	21027
@NP	pb0 .001	21027
@NP	F2 ,34 = 23.3	21036
@NP	F2 ,34	21036
@NP	= 23.3	21041
@NP	three-way ANOVA	21048
@NP	all time-points -LRB- pb0 .03 , t5N2 .5 , posthoc Tukey 's tests -RRB-	21085
@NP	all time-points	21085
@NP	pb0 .03 , t5N2 .5 , posthoc Tukey 's tests	21102
@NP	pb0 .03	21102
@NP	t5N2 .5 , posthoc Tukey 's tests	21110
@NP	t5N2 .5	21110
@NP	posthoc Tukey 's tests	21118
@NP	posthoc Tukey 's	21118
@NP	The change in cavity size	21142
@NP	The change	21142
@NP	cavity size	21156
@NP	segments rostral and caudal	21183
@NP	segments	21183
@NP	the lesion -LRB- p = 1 , F2 ,34 = 0.02 , three-way ANOVA -RRB-	21214
@NP	the lesion	21214
@NP	p = 1 , F2 ,34 = 0.02 , three-way ANOVA	21226
@NP	p = 1	21226
@NP	p	21226
@NP	1	21228
@NP	F2 ,34 = 0.02	21231
@NP	F2 ,34	21231
@NP	0.02	21237
@NP	three-way ANOVA	21243
@NP	three-way	21243
@NP	ANOVA	21253
@NP	non-cavity tissue loss	21265
@NP	no clear trend	21289
@NP	rostral or caudal	21320
@NP	the lesion -LRB- pN0 .2 , F2 ,34 b1 .6 , three-way ANOVA -RRB-	21341
@NP	the lesion	21341
@NP	pN0 .2 , F2 ,34 b1 .6 , three-way ANOVA	21353
@NP	pN0 .2	21353
@NP	F2 ,34 b1 .6	21360
@NP	F2 ,34	21360
@NP	b1 .6	21365
@NP	three-way ANOVA	21371
@NP	all times	21392
@NP	non-cavity tissue loss	21402
@NP	10 % of the delineated rostral and caudal areas	21443
@NP	10 %	21443
@NP	the delineated rostral and caudal areas	21450
@NP	the	21450
@NP	rostral and caudal areas	21465
@NP	rostral	21465
@NP	caudal areas	21477
@NP	Fig. 4	21509
@NP	the OEC-treated animals	21520
@NP	there	21544
@NP	a slower increase	21554
@NP	cavitation compared to the control animals	21575
@NP	cavitation	21575
@NP	the control animals	21598
@NP	this trend	21628
@NP	statistical significance -LRB- p = 0.07 , F2 ,34 = 2.8 , three-way ANOVA -RRB-	21653
@NP	statistical significance	21653
@NP	p = 0.07 , F2 ,34 = 2.8 , three-way ANOVA	21679
@NP	p = 0.07	21679
@NP	p	21679
@NP	0.07	21681
@NP	F2 ,34 = 2.8	21687
@NP	F2 ,34	21687
@NP	2.8	21693
@NP	three-way ANOVA	21698
@NP	three-way	21698
@NP	ANOVA	21708
@NP	cavity tissue loss between the OEC-treated and the control groups at week 9	21746
@NP	cavity tissue loss between the OEC-treated	21746
@NP	cavity tissue loss	21746
@NP	the OEC-treated	21773
@NP	the control groups at week 9	21793
@NP	the control groups	21793
@NP	week 9	21815
@NP	the effect of Treatment	21834
@NP	the effect	21834
@NP	Treatment	21848
@NP	p = 0.05 , F1 ,11 = 4.3 , two-way ANOVA	21889
@NP	p = 0.05	21889
@NP	p	21889
@NP	0.05	21891
@NP	F1 ,11 = 4.3	21897
@NP	F1 ,11	21897
@NP	4.3	21903
@NP	two-way ANOVA	21908
@NP	two-way	21908
@NP	ANOVA	21916
@NP	contrast	21927
@NP	no consistent trends in the non-cavity tissue loss	21937
@NP	no consistent trends	21937
@NP	the non-cavity tissue loss	21961
@NP	the OEC transplantation were seen	22001
@NP	the OEC transplantation	22001
@NP	p ≥	22036
@NP	0.3 , F2 ,34 ≤ 1.2 , three-way ANOVA	22038
@NP	0.3	22038
@NP	F2 ,34 ≤ 1.2	22043
@NP	F2 ,34	22043
@NP	≤ 1.2	22048
@NP	three-way ANOVA	22054
@NP	the data	22092
@NP	week 9 separately -LRB- p = 0.6 , F1 ,11 = 0.3 , two-way ANOVA -RRB-	22104
@NP	week 9 separately	22104
@NP	week 9	22104
@NP	p = 0.6 , F1 ,11 = 0.3 , two-way ANOVA	22123
@NP	p = 0.6	22123
@NP	p	22123
@NP	0.6	22125
@NP	F1 ,11 = 0.3	22130
@NP	F1 ,11	22130
@NP	0.3	22136
@NP	two-way ANOVA	22141
@NP	two-way	22141
@NP	ANOVA	22149
@NP	The association between cavity and non-cavity tissue loss	22157
@NP	The association	22157
@NP	cavity and non-cavity tissue loss	22181
@NP	The relation between the two variables	22229
@NP	The relation	22229
@NP	the two variables	22250
@NP	a linear regression analysis -LRB- R2 = 10 − 6 ; p = 0.99 -RRB-	22294
@NP	a linear regression analysis	22294
@NP	R2 = 10 − 6 ; p = 0.99	22324
@NP	R2	22324
@NP	= 10 − 6 ; p = 0.99	22326
@NP	= 10 − 6	22326
@NP	= 10	22326
@NP	− 6	22329
@NP	p = 0.99	22333
@NP	p	22333
@NP	0.99	22335
@NP	3.2	22342
@NP	Morphometric features of SPNs The effect of injury on SPN morphology	22347
@NP	Morphometric features	22347
@NP	SPNs The effect of injury on SPN morphology	22372
@NP	SPNs	22372
@NP	The effect of injury on SPN morphology	22377
@NP	The effect	22377
@NP	injury on SPN morphology	22391
@NP	injury	22391
@NP	SPN morphology	22401
@NP	the values recorded in the intact and the control groups -LRB- Fig. 5 -RRB-	22443
@NP	the values	22443
@NP	the intact and the control groups -LRB- Fig. 5 -RRB-	22466
@NP	the intact and the control groups	22466
@NP	the control	22481
@NP	Fig. 5	22501
@NP	Injury	22510
@NP	an increase	22524
@NP	soma size rostral and caudal	22539
@NP	soma size rostral	22539
@NP	caudal	22561
@NP	the lesion -LRB- pb0 .001 , F3 ,21 = 4.2 , linear mixed model -RRB-	22571
@NP	the lesion	22571
@NP	pb0 .001 , F3 ,21 = 4.2 , linear mixed model	22583
@NP	pb0 .001	22583
@NP	F3 ,21 = 4.2	22592
@NP	F3 ,21	22592
@NP	4.2	22598
@NP	linear mixed model	22603
@NP	This increase	22624
@NP	the 9 weeks following transection	22696
@NP	the 9 weeks	22696
@NP	transection	22718
@NP	Overall dendritic length of the examined SPNs	22731
@NP	Overall dendritic length	22731
@NP	the examined SPNs	22759
@NP	a similar trend	22784
@NP	SCI	22818
@NP	the increase	22833
@NP	soma size	22898
@NP	the increase	22909
@NP	dendritic lengthwas	22925
@NP	weeks 1 and 4	22978
@NP	values at week 9 post-injury	22998
@NP	values	22998
@NP	week 9 post-injury	23008
@NP	week	23008
@NP	those in the intact animals	23038
@NP	those	23038
@NP	the intact animals	23047
@NP	The statistical analysis	23067
@NP	a significant effect of Time post-injury	23102
@NP	a significant effect	23102
@NP	Time post-injury	23126
@NP	p	23144
@NP	= 0.004 , F3 ,21 = 2.1 , linear mixed model	23145
@NP	= 0.004	23145
@NP	F3 ,21 = 2.1	23153
@NP	F3 ,21	23153
@NP	2.1	23159
@NP	linear mixed model	23164
@NP	weeks 1 and 4	23201
@NP	week 9 in the SPNs rostral	23219
@NP	week 9	23219
@NP	the SPNs rostral	23229
@NP	the lesion -LRB- p ≤ 0.01 , t55 ≥ 2.4 , post-hoc Tukey 's tests -RRB-	23249
@NP	the lesion	23249
@NP	p ≤ 0.01 , t55 ≥ 2.4 , post-hoc Tukey 's tests	23261
@NP	p ≤ 0.01	23261
@NP	p	23261
@NP	≤ 0.01	23262
@NP	t55 ≥ 2.4	23269
@NP	t55	23269
@NP	≥ 2.4	23272
@NP	post-hoc Tukey 's tests	23278
@NP	post-hoc	23278
@NP	Tukey 's tests	23287
@NP	Tukey 's	23287
@NP	dendritic length	23314
@NP	SCI	23332
@NP	a temporary increase	23346
@NP	the number	23370
@NP	primary dendrites of the rostral and caudal SPNs	23384
@NP	primary dendrites	23384
@NP	the rostral and caudal SPNs	23405
@NP	the rostral	23405
@NP	caudal SPNs	23421
@NP	9 weeks post-injury -LRB- pb0 .001 , F3 ,21 = 8.8 , linear mixed model -RRB-	23452
@NP	9 weeks post-injury	23452
@NP	pb0 .001 , F3 ,21 = 8.8 , linear mixed model	23473
@NP	pb0 .001	23473
@NP	F3 ,21 = 8.8	23482
@NP	F3 ,21	23482
@NP	8.8	23488
@NP	linear mixed model	23493
@NP	the effect ofOEC transplantation	23526
@NP	morphometric features of SPNs in the OEC-treated rats	23559
@NP	morphometric features	23559
@NP	SPNs in the OEC-treated rats	23584
@NP	SPNs	23584
@NP	the OEC-treated rats	23592
@NP	those in the control groups -LRB- Fig. 5 -RRB-	23630
@NP	those	23630
@NP	the control groups -LRB- Fig. 5 -RRB-	23639
@NP	the control groups	23639
@NP	Fig. 5	23659
@NP	soma size of the rostral SPNs	23674
@NP	soma size	23674
@NP	the rostral SPNs	23687
@NP	the groups	23727
@NP	somata of the caudal SPNs in the OEC-treated animals	23739
@NP	somata	23739
@NP	the caudal SPNs in the OEC-treated animals	23749
@NP	the caudal SPNs	23749
@NP	the OEC-treated animals	23768
@NP	week 9 post-injury	23808
@NP	week	23808
@NP	These observations	23828
@NP	the linear mixed model analysis	23867
@NP	a significant interaction effect	23913
@NP	Treatment × Time post-injury × Position -LRB- p = 0.04 , F2 ,786 = 3.7 -RRB-	23949
@NP	Treatment × Time post-injury × Position	23949
@NP	Treatment × Time	23949
@NP	× Position	23975
@NP	p = 0.04 , F2 ,786 = 3.7	23986
@NP	p	23986
@NP	= 0.04 , F2 ,786 = 3.7	23987
@NP	= 0.04	23987
@NP	F2 ,786 = 3.7	23994
@NP	F2 ,786	23994
@NP	3.7	24001
@NP	Post-hoc analysis	24007
@NP	a significant effect of Treatment	24031
@NP	a significant effect	24031
@NP	Treatment	24055
@NP	the caudal SPNs atweek 9 post-injury -LRB- p = 0.02 , t59 = 2.1 , t-test -RRB-	24068
@NP	the caudal SPNs atweek 9 post-injury	24068
@NP	the caudal SPNs	24068
@NP	p	24106
@NP	= 0.02 , t59 = 2.1 , t-test	24107
@NP	= 0.02	24107
@NP	t59 = 2.1	24114
@NP	t59	24114
@NP	2.1	24118
@NP	t-test	24123
@NP	the other time-points -LRB- p ≥ 0.2 , t54 ≤ 0.8 , t-tests -RRB-	24142
@NP	the other time-points	24142
@NP	p ≥	24165
@NP	0.2 , t54 ≤ 0.8 , t-tests	24167
@NP	0.2	24167
@NP	t54 ≤ 0.8	24172
@NP	t54	24172
@NP	≤ 0.8	24175
@NP	t-tests	24181
@NP	Overall dendritic length of the rostral SPNs in the OEC-treated groups	24190
@NP	Overall dendritic length	24190
@NP	the rostral SPNs in the OEC-treated groups	24218
@NP	the rostral SPNs	24218
@NP	the OEC-treated groups	24238
@NP	the dendritic lengths in the control groups at all time-points	24270
@NP	the dendritic lengths	24270
@NP	the control groups at all time-points	24295
@NP	the control groups	24295
@NP	all time-points	24317
@NP	Caudal to the lesion , a similar trend	24346
@NP	Caudal	24346
@NP	the lesion , a similar trend	24356
@NP	the lesion	24356
@NP	a similar trend	24368
@NP	week 1	24396
@NP	SCI	24409
@NP	this trend	24422
@NP	the later time-points	24449
@NP	The linear mixed model analysis	24472
@NP	significant interaction effects	24511
@NP	Treatment × Position -LRB- p = 0.02 , F1 ,786 = 6.2 -RRB-	24546
@NP	Treatment × Position	24546
@NP	p = 0.02 , F1 ,786 = 6.2	24566
@NP	p	24566
@NP	= 0.02 , F1 ,786 = 6.2	24567
@NP	= 0.02	24567
@NP	F1 ,786 = 6.2	24574
@NP	F1 ,786	24574
@NP	6.2	24581
@NP	Treatment × Time postinjury × Position -LRB- p = 0.03 , F2 ,786 = 3.7 -RRB-	24590
@NP	Treatment × Time	24590
@NP	postinjury × Position -LRB- p = 0.03 , F2 ,786 = 3.7 -RRB-	24605
@NP	postinjury × Position	24605
@NP	p = 0.03 , F2 ,786 = 3.7	24626
@NP	p	24626
@NP	= 0.03 , F2 ,786 = 3.7	24627
@NP	= 0.03	24627
@NP	F2 ,786 = 3.7	24634
@NP	F2 ,786	24634
@NP	3.7	24641
@NP	a close-to-significant effect of Treatment -LRB- p = 0.051 , F1 ,36 = 1.4 -RRB-	24650
@NP	a close-to-significant effect	24650
@NP	Treatment -LRB- p = 0.051 , F1 ,36 = 1.4 -RRB-	24683
@NP	Treatment	24683
@NP	p = 0.051 , F1 ,36 = 1.4	24694
@NP	p	24694
@NP	= 0.051 , F1 ,36 = 1.4	24695
@NP	= 0.051	24695
@NP	F1 ,36 = 1.4	24703
@NP	F1 ,36	24703
@NP	1.4	24709
@NP	Post-hoc analysis	24715
@NP	a significant effect of Treatment	24739
@NP	a significant effect	24739
@NP	Treatment	24763
@NP	the rostral SPNs	24776
@NP	week 9 post-injury -LRB- p = 0.007 , t58 = 2.7 , t-test -RRB-	24796
@NP	week 9 post-injury	24796
@NP	week	24796
@NP	p	24816
@NP	= 0.007 , t58 = 2.7 , t-test	24817
@NP	= 0.007	24817
@NP	t58 = 2.7	24825
@NP	t58	24825
@NP	2.7	24829
@NP	t-test	24834
@NP	the control animals	24860
@NP	the dendritic length	24881
@NP	the pre-injury levels	24920
@NP	the previously described morphometric features	24950
@NP	the number of primary dendrites in theOEC-treated groups	24998
@NP	the number	24998
@NP	primary dendrites in theOEC-treated groups	25012
@NP	primary dendrites	25012
@NP	theOEC-treated groups	25033
@NP	showa consistent pattern of increase or decrease	25063
@NP	showa consistent pattern	25063
@NP	increase or decrease	25091
@NP	the control groups	25130
@NP	fact	25153
@NP	the linear mixed model analysis	25159
@NP	an interaction effect of Treatment × Time post-injury × Position	25197
@NP	an interaction effect	25197
@NP	Treatment × Time post-injury × Position	25222
@NP	Treatment × Time	25222
@NP	× Position	25249
@NP	primary dendrite numbers -LRB- p = 0.03 , F2 ,786 = 4.1 -RRB-	25262
@NP	primary dendrite numbers	25262
@NP	p = 0.03 , F2 ,786 = 4.1	25288
@NP	p	25288
@NP	= 0.03 , F2 ,786 = 4.1	25289
@NP	= 0.03	25289
@NP	F2 ,786 = 4.1	25296
@NP	F2 ,786	25296
@NP	Post-hoc analysis	25309
@NP	a significant effect of Treatment	25334
@NP	a significant effect	25334
@NP	Treatment	25358
@NP	the rostral SPNs at week 9 post-injury -LRB- p = 0.04 , t58 = 1.7 , t-test -RRB-	25371
@NP	the rostral SPNs	25371
@NP	week 9 post-injury -LRB- p = 0.04 , t58 = 1.7 , t-test -RRB-	25391
@NP	week 9 post-injury	25391
@NP	week	25391
@NP	p	25411
@NP	= 0.04 , t58 = 1.7 , t-test	25412
@NP	= 0.04	25412
@NP	t58 = 1.7	25419
@NP	t58	25419
@NP	1.7	25423
@NP	t-test	25428
@NP	summary	25440
@NP	soma size , dendritic length and number of primary dendrites	25449
@NP	soma size	25449
@NP	dendritic length and number of primary dendrites	25460
@NP	dendritic length and number	25460
@NP	primary dendrites	25491
@NP	SCI	25529
@NP	both rostral and caudal segments	25536
@NP	both rostral	25536
@NP	caudal segments	25553
@NP	This increase	25570
@NP	9 weeks for soma size	25598
@NP	9 weeks	25598
@NP	soma size	25610
@NP	the overall dendritic length and the number of primary dendrites	25647
@NP	the overall dendritic length	25647
@NP	the number of primary dendrites	25680
@NP	the number	25680
@NP	primary dendrites	25694
@NP	The significant effects of OECs	25713
@NP	The significant effects	25713
@NP	OECs	25740
@NP	9 weeks	25766
@NP	they	25779
@NP	a reduction	25791
@NP	pre-injury values for caudal soma size	25811
@NP	pre-injury values	25811
@NP	caudal soma size	25833
@NP	the increase	25865
@NP	the number and length of dendrites in the rostral cord	25881
@NP	the number and length	25881
@NP	dendrites in the rostral cord	25906
@NP	dendrites	25906
@NP	the rostral cord	25919
@NP	3.3	25937
@NP	Primary afferent fibre density	25942
@NP	the dorsal horn	25976
@NP	The density	25992
@NP	the CGRP-positive primary afferent fibres in laminae I , II , III+IV and V	26007
@NP	the CGRP-positive primary afferent fibres	26007
@NP	laminae I , II , III+IV and V	26052
@NP	laminae I	26052
@NP	II	26063
@NP	III+IV	26067
@NP	V	26078
@NP	the cross-sections	26096
@NP	the spinal cord at the T1 and T7 segments	26123
@NP	the spinal cord	26123
@NP	the T1 and T7 segments	26142
@NP	the intact animals and the animals	26168
@NP	the intact animals	26168
@NP	the animals	26191
@NP	1 and 4 weeks	26206
@NP	the spinal cord tissue at week 9	26233
@NP	the spinal cord tissue	26233
@NP	week 9	26259
@NP	this analysis	26288
@NP	Fig. 6	26322
@NP	density of the CGRP-positive fibres in intact animals	26330
@NP	density	26330
@NP	the CGRP-positive fibres in intact animals	26341
@NP	the CGRP-positive fibres	26341
@NP	intact animals	26369
@NP	highest in laminae I and II	26388
@NP	highest	26388
@NP	laminae I and II	26399
@NP	laminae I	26399
@NP	II	26413
@NP	relatively low levels found in laminae III -- V.	26422
@NP	relatively low levels	26422
@NP	laminae III -- V.	26453
@NP	laminae III	26453
@NP	V.	26465
@NP	SCI	26478
@NP	CGRP density	26483
@NP	time in laminae I -- IV , particularly caudal	26528
@NP	time	26528
@NP	laminae I -- IV , particularly caudal	26536
@NP	laminae I	26536
@NP	laminae	26536
@NP	I	26544
@NP	IV	26546
@NP	the lesion	26573
@NP	The increase in the lamina II	26585
@NP	The increase	26585
@NP	the lamina II	26601
@NP	the level	26623
@NP	statistical significance -LRB- p = 0.04 , F2 ,29 = 4.3 , three-way ANOVA -RRB-	26636
@NP	statistical significance	26636
@NP	p = 0.04 , F2 ,29 = 4.3 , three-way ANOVA	26662
@NP	p = 0.04	26662
@NP	p	26662
@NP	0.04	26664
@NP	F2 ,29 = 4.3	26670
@NP	F2 ,29	26670
@NP	4.3	26676
@NP	three-way ANOVA	26681
@NP	three-way	26681
@NP	ANOVA	26691
@NP	the T7 segment	26715
@NP	week 4 post-injury -LRB- p = 0.05 , t5 = 2 , Tukey 's tests -RRB-	26733
@NP	week 4 post-injury	26733
@NP	week	26733
@NP	p = 0.05 , t5 = 2 , Tukey 's tests	26753
@NP	p = 0.05	26753
@NP	p	26753
@NP	0.05	26755
@NP	t5 = 2	26761
@NP	t5	26761
@NP	2	26764
@NP	Tukey 's tests	26767
@NP	Tukey 's	26767
@NP	tests	26775
@NP	No effect of the OEC transplantation on the afferent fibre density	26783
@NP	No effect	26783
@NP	the OEC transplantation on the afferent fibre density	26796
@NP	the OEC transplantation	26796
@NP	the afferent fibre density	26823
@NP	SPNs rostral or caudal	26866
@NP	SPNs rostral	26866
@NP	caudal	26882
@NP	the lesion	26892
@NP	The differences between the OEC-treated and the control groups	26904
@NP	The differences	26904
@NP	the OEC-treated and the control groups	26928
@NP	the OEC-treated	26928
@NP	the control groups	26948
@NP	any consistent trends	26995
@NP	This observation	27018
@NP	a three-way ANOVA -LRB- p ≥ 0.2 , F2 ,29 ≤ 1.8 -RRB-	27054
@NP	a three-way ANOVA	27054
@NP	p ≥ 0.2 , F2 ,29 ≤ 1.8	27073
@NP	p	27073
@NP	≥ 0.2 , F2 ,29 ≤ 1.8	27074
@NP	≥ 0.2	27074
@NP	F2 ,29 ≤ 1.8	27080
@NP	F2 ,29	27080
@NP	≤ 1.8	27085
@NP	Discussion	27096
@NP	the rat model of T4 transection	27113
@NP	the rat model	27113
@NP	T4 transection	27130
@NP	we	27146
@NP	complete SCI	27165
@NP	formation of gradually expanding cavities both rostral and caudal to the lesion	27187
@NP	formation	27187
@NP	cavities both rostral and caudal	27220
@NP	cavities	27220
@NP	rostral and caudal	27234
@NP	the lesion	27256
@NP	shrinkage	27275
@NP	the spinal cord tissue	27288
@NP	the insult	27337
@NP	the injury	27387
@NP	temporary as well as more prolonged changes	27409
@NP	the morphology of SPNs adjacent to the lesion	27456
@NP	the morphology	27456
@NP	SPNs adjacent to the lesion	27474
@NP	SPNs	27474
@NP	the lesion	27491
@NP	the CGRP-positive primary afferent fibres within the dorsal horn caudal	27529
@NP	the CGRP-positive primary afferent fibres	27529
@NP	the dorsal horn caudal	27578
@NP	the lesion	27604
@NP	we	27625
@NP	OEC transplants	27651
@NP	the changes in SPNs	27673
@NP	the changes	27673
@NP	SPNs	27688
@NP	the injury	27709
@NP	the injury-induced cavity formation	27731
@NP	the sprouting of CGRP-positive afferent fibres	27785
@NP	the sprouting	27785
@NP	CGRP-positive afferent fibres	27802
@NP	4.1	27833
@NP	Morphological changes	27838
@NP	the spinal cord	27867
@NP	T4 transection	27893
@NP	We	27908
@NP	transection of the spinal cord	27927
@NP	transection	27927
@NP	the spinal cord	27942
@NP	formation of cavities	27969
@NP	formation	27969
@NP	cavities	27982
@NP	overall shrinkage	28005
@NP	the nervous tissue , evidenced by narrowing of the cord near the injury site	28026
@NP	the nervous tissue	28026
@NP	narrowing of the cord near the injury site	28059
@NP	narrowing	28059
@NP	the cord near the injury site	28072
@NP	the cord	28072
@NP	the injury site	28086
@NP	rostral and caudal to the lesion	28108
@NP	rostral and caudal	28108
@NP	the lesion	28130
@NP	These changes	28142
@NP	1 week of the traumatic event	28169
@NP	1 week	28169
@NP	the traumatic event	28179
@NP	the case of cavitation	28207
@NP	the case	28207
@NP	cavitation	28219
@NP	at least 9 weeks	28243
@NP	the extent of non-cavity tissue loss	28270
@NP	the extent	28270
@NP	non-cavity tissue loss	28284
@NP	1 week	28329
@NP	This	28349
@NP	the shrinkage of the injured cord	28369
@NP	the shrinkage	28369
@NP	the injured cord	28386
@NP	the expanding cavitation	28421
@NP	the direct result of retraction of the cut stumps at the time of transection	28457
@NP	the direct result	28457
@NP	retraction of the cut stumps at the time of transection	28478
@NP	retraction	28478
@NP	the cut stumps at the time of transection	28492
@NP	the cut stumps	28492
@NP	the time of transection	28510
@NP	the time	28510
@NP	transection	28522
@NP	formation of cavities	28547
@NP	formation	28547
@NP	cavities	28560
@NP	a sensitive marker of the spread of secondary injury	28580
@NP	a sensitive marker	28580
@NP	the spread of secondary injury	28602
@NP	the spread	28602
@NP	secondary injury	28616
@NP	one of the principal obstacles of the spinal cord regeneration	28640
@NP	one	28640
@NP	the principal obstacles of the spinal cord regeneration	28647
@NP	the principal obstacles	28647
@NP	the spinal cord regeneration	28674
@NP	we	28717
@NP	the cord transection	28735
@NP	an increase in soma size , overall dendritic length	28765
@NP	an increase	28765
@NP	soma size , overall dendritic length	28780
@NP	soma size	28780
@NP	overall dendritic length	28791
@NP	number of primary dendrites of the SPNs adjacent to the lesion	28823
@NP	number	28823
@NP	primary dendrites of the SPNs adjacent to the lesion	28833
@NP	primary dendrites	28833
@NP	the SPNs adjacent to the lesion	28854
@NP	the SPNs	28854
@NP	the lesion	28875
@NP	The dendritic changes	28887
@NP	9 weeks of SCI	28941
@NP	9 weeks	28941
@NP	SCI	28952
@NP	The increase in soma size of the SPNs	28957
@NP	The increase	28957
@NP	soma size of the SPNs	28973
@NP	soma size	28973
@NP	the SPNs	28986
@NP	a more permanent nature , as it is apparent at least until 9 weeks post-injury	29001
@NP	a more permanent nature	29001
@NP	it	29029
@NP	9 weeks	29059
@NP	The changes in soma size and in overall dendritic length	29080
@NP	The changes	29080
@NP	soma size	29095
@NP	overall dendritic length	29112
@NP	SPNs rostral	29160
@NP	those	29185
@NP	the lesion , while the changes in number of dendrites do not differ above	29201
@NP	the lesion	29201
@NP	the changes in number of dendrites	29219
@NP	the changes	29219
@NP	number of dendrites	29234
@NP	number	29234
@NP	dendrites	29244
@NP	the injury	29284
@NP	The plasticity of a specific group of SPNs labelled from the adrenal medulla	29296
@NP	The plasticity	29296
@NP	a specific group of SPNs labelled from the adrenal medulla	29314
@NP	a specific group	29314
@NP	SPNs labelled from the adrenal medulla	29334
@NP	SPNs	29334
@NP	the adrenal medulla	29353
@NP	previous studies	29394
@NP	Krassioukov and Weaver , 1995	29412
@NP	Krassioukov and Weaver	29412
@NP	1995	29436
@NP	1996 ; Krenz and Weaver , 1998a	29442
@NP	1996	29442
@NP	Krenz and Weaver , 1998a	29448
@NP	Krenz and Weaver	29448
@NP	1998a	29466
@NP	these earlier reports	29483
@NP	ours	29517
@NP	several critical aspects	29525
@NP	No changes in SPN morphology	29551
@NP	No changes	29551
@NP	SPN morphology	29565
@NP	soma size , dendritic length or number of primary dendrites	29581
@NP	soma size	29581
@NP	dendritic length	29592
@NP	number of primary dendrites	29612
@NP	number	29612
@NP	primary dendrites	29622
@NP	caudally all measures	29671
@NP	1 week	29708
@NP	injury	29721
@NP	Krassioukov and Weaver , 1995	29729
@NP	Krassioukov	29729
@NP	Weaver , 1995	29745
@NP	Weaver	29745
@NP	1995	29753
@NP	A later study	29760
@NP	these caudal changes	29788
@NP	2 weeks	29826
@NP	the appearance of these cells at longer time-points -LRB- day 30 -RRB-	29839
@NP	the appearance	29839
@NP	these cells at longer time-points -LRB- day 30 -RRB-	29857
@NP	these cells	29857
@NP	longer time-points -LRB- day 30 -RRB-	29872
@NP	longer time-points	29872
@NP	day 30	29892
@NP	this	29918
@NP	Krassioukov and Weaver	29947
@NP	1996	29971
@NP	Reasons for these discrepancies in SPN plasticity	29978
@NP	Reasons	29978
@NP	these discrepancies in SPN plasticity	29990
@NP	these discrepancies	29990
@NP	SPN plasticity	30013
@NP	all cases	30047
@NP	complete transections	30057
@NP	the cord at similar levels -LRB- T4 here ; T5 in the cited works -RRB-	30082
@NP	the cord	30082
@NP	similar levels	30094
@NP	T4 here ; T5	30110
@NP	T4 here	30110
@NP	T5	30119
@NP	the cited works	30125
@NP	the compared studies	30157
@NP	the	30157
@NP	studies	30170
@NP	measurements of the same morphological features	30187
@NP	measurements	30187
@NP	the same morphological features	30203
@NP	It	30236
@NP	SPNs projecting to the adrenal gland	30256
@NP	SPNs	30256
@NP	the adrenal gland	30275
@NP	other SPNs	30317
@NP	Krassioukov and Weaver	30338
@NP	similar changes in morphology	30374
@NP	similar changes	30374
@NP	morphology	30393
@NP	all SPNs visualised by NADPH staining	30442
@NP	all SPNs	30442
@NP	NADPH staining	30465
@NP	Plasticity of SPNs	30495
@NP	Plasticity	30495
@NP	SPNs	30509
@NP	a likely mechanism	30517
@NP	the development of autonomic dysreflexia	30552
@NP	the development	30552
@NP	autonomic dysreflexia	30571
@NP	further investigation.We	30614
@NP	our observation	30652
@NP	the transient increase	30671
@NP	dendritic length	30697
@NP	number of primary dendrites	30721
@NP	number	30721
@NP	primary dendrites	30731
@NP	the more permanent increase in soma size in SPNs	30760
@NP	the more permanent increase	30760
@NP	soma size in SPNs	30791
@NP	soma size	30791
@NP	SPNs	30804
@NP	rostral and caudal to the lesion	30814
@NP	rostral and caudal	30814
@NP	the lesion	30836
@NP	a compensatory reaction of these neurons	30864
@NP	a compensatory reaction	30864
@NP	these neurons	30891
@NP	the loss of a considerable proportion of their input	30908
@NP	the loss	30908
@NP	a considerable proportion of their input	30920
@NP	a considerable proportion	30920
@NP	their input	30949
@NP	Llewellyn-Smith	30962
@NP	et al. , 2006	30978
@NP	et al.	30978
@NP	2006	30986
@NP	Increase in the size of their somata and of their dendritic trees	30993
@NP	Increase	30993
@NP	the size of their somata	31005
@NP	the size	31005
@NP	their somata	31017
@NP	their dendritic trees	31037
@NP	an attempt to regain lost synapses	31078
@NP	lost synapses	31099
@NP	the decrease	31145
@NP	the synaptic density	31161
@NP	SPNs -LRB- Llewellyn-Smith and Weaver , 2001 -RRB-	31194
@NP	SPNs	31194
@NP	Llewellyn-Smith and Weaver , 2001	31200
@NP	Llewellyn-Smith	31200
@NP	Weaver , 2001	31220
@NP	Weaver	31220
@NP	2001	31228
@NP	T4 transection	31244
@NP	a gradual increase in density of CGRP	31270
@NP	a gradual increase	31270
@NP	density of CGRP	31292
@NP	density	31292
@NP	CGRP	31303
@NP	positive primary afferent fibres	31308
@NP	Rexed lamina II below the lesion -LRB- here tested within the segment T7 -RRB-	31344
@NP	Rexed lamina II	31344
@NP	the lesion	31366
@NP	the segment T7	31397
@NP	This	31414
@NP	agreement	31425
@NP	earlier works	31440
@NP	a similar increase	31470
@NP	the afferent fibre	31517
@NP	the dorsal horn	31553
@NP	the lower thoracic , lumbar and sacral segments	31586
@NP	Christensen and Hulsebosch , 1997 ; Hou et al. , 2009	31634
@NP	Christensen and Hulsebosch	31634
@NP	1997 ; Hou et al.	31662
@NP	1997	31662
@NP	Hou et al.	31668
@NP	Hou	31668
@NP	et al.	31672
@NP	2009	31680
@NP	these works	31699
@NP	we	31712
@NP	the afferent fibre sprouting	31736
@NP	the afferent fibre	31736
@NP	the segments remote from the injury epicentre	31788
@NP	the segments remote	31788
@NP	the injury epicentre	31813
@NP	the segment T7 , i.e. three levels caudal to the lesion	31851
@NP	the segment T7	31851
@NP	i.e. three levels caudal to the lesion	31867
@NP	i.e.	31867
@NP	three levels	31872
@NP	the lesion	31895
@NP	This sprouting	31907
@NP	This	31907
@NP	nerve growth factor -LRB- NGF -RRB-	31950
@NP	nerve growth factor	31950
@NP	NGF	31971
@NP	the formation of abnormal connections	32007
@NP	the formation	32007
@NP	abnormal connections	32024
@NP	the caudal segments	32052
@NP	the spinal cord	32075
@NP	their descending regulatory inputs	32118
@NP	supraspinal nuclei	32158
@NP	Cameron	32178
@NP	et al. , 2006 ; Krenz and Weaver , 1998b	32186
@NP	et al.	32186
@NP	2006 ; Krenz and Weaver	32194
@NP	2006	32194
@NP	Krenz and Weaver	32200
@NP	1998b	32218
@NP	It	32226
@NP	this abnormal intraspinal circuitry	32243
@NP	an important role	32285
@NP	the development of pathological reflexes , such as autonomic dysreflexia	32306
@NP	the development	32306
@NP	pathological reflexes	32325
@NP	autonomic dysreflexia	32356
@NP	it	32388
@NP	the intraspinal plasticity triggered by the SCI	32413
@NP	the intraspinal plasticity	32413
@NP	the SCI	32453
@NP	augmentation of some physiological reflexes	32484
@NP	augmentation	32484
@NP	some physiological reflexes	32500
@NP	some of the autonomic functions , e.g. local response of vasculature	32560
@NP	some	32560
@NP	the autonomic functions , e.g. local response of vasculature	32568
@NP	the autonomic functions , e.g. local response	32568
@NP	functions , e.g.	32582
@NP	functions	32582
@NP	e.g.	32593
@NP	vasculature	32616
@NP	the change in the environmental temperature -LRB- Kalincik et al. , 2009 -RRB-	32631
@NP	the change	32631
@NP	the environmental temperature -LRB- Kalincik et al. , 2009 -RRB-	32645
@NP	the environmental temperature	32645
@NP	Kalincik	32676
@NP	et al. , 2009	32685
@NP	et al.	32685
@NP	2009	32693
@NP	4.2	32700
@NP	Effect of OECs on the morphological changes in the injured spinal cord We	32705
@NP	Effect	32705
@NP	OECs on the morphological changes in the injured spinal cord We	32715
@NP	OECs	32715
@NP	the morphological changes in the injured spinal cord We	32723
@NP	the morphological changes	32723
@NP	the injured spinal cord We	32752
@NP	a trend	32790
@NP	OEC transplantation	32802
@NP	cavity formation both rostral and caudal	32836
@NP	cavity formation	32836
@NP	rostral and caudal	32858
@NP	the spinal cord lesion	32880
@NP	an effect	32904
@NP	Plant et al. , 2003 ; Ramer et al. , 2004 ; Verdu et al. , 2003	32945
@NP	Plant	32945
@NP	et al. , 2003 ; Ramer et al. , 2004 ; Verdu et al. , 2003	32951
@NP	et al. , 2003	32951
@NP	et al.	32951
@NP	2003	32959
@NP	Ramer et al. , 2004	32965
@NP	Ramer	32965
@NP	et al. , 2004	32971
@NP	et al.	32971
@NP	2004	32979
@NP	Verdu et al. , 2003	32985
@NP	Verdu	32985
@NP	et al. , 2003	32991
@NP	et al.	32991
@NP	2003	32999
@NP	It	33006
@NP	our study	33050
@NP	the purpose of the cavity size analysis	33081
@NP	the purpose	33081
@NP	the cavity size analysis	33096
@NP	the level of statistical significance	33125
@NP	the level	33125
@NP	statistical significance	33138
@NP	week 9	33183
@NP	the other two time-points	33220
@NP	It	33247
@NP	OECs	33267
@NP	a protective effect on the nervous tissue adjacent to the lesion	33277
@NP	a protective effect	33277
@NP	the nervous tissue adjacent to the lesion	33300
@NP	the nervous tissue	33300
@NP	the lesion	33331
@NP	The OEC-mediated reduction in the spread of secondary injury	33343
@NP	The OEC-mediated reduction	33343
@NP	the spread of secondary injury	33373
@NP	the spread	33373
@NP	secondary injury	33387
@NP	a role	33415
@NP	the amelioration of autonomic dysreflexia	33425
@NP	the amelioration	33425
@NP	autonomic dysreflexia	33445
@NP	we	33471
@NP	elsewhere -LRB- Kalincik et al. , 2010 -RRB-	33484
@NP	elsewhere	33484
@NP	Kalincik	33495
@NP	et al. , 2010	33504
@NP	et al.	33504
@NP	2010	33512
@NP	the other hand	33522
@NP	overall shrinkage	33538
@NP	the nervous tissue	33559
@NP	non-cavity tissue loss	33598
@NP	the OEC transplantation	33643
@NP	our hypothesis	33681
@NP	non-cavity tissue loss	33701
@NP	the traumatic event	33751
@NP	static	33794
@NP	it	33802
@NP	the therapeutic regimens	33837
@NP	morphological and structural effects	33869
@NP	obvious only days or weeks	33913
@NP	SCI	33946
@NP	The changes	33951
@NP	the morphometric features initiated by the spinal cord transection	33966
@NP	the morphometric features	33966
@NP	the spinal cord transection	34005
@NP	9 weeks	34046
@NP	the OEC transplantation	34060
@NP	it	34088
@NP	the data from our previous work -LRB- Kalincik et al. , 2010 -RRB-	34104
@NP	the data	34104
@NP	our previous work -LRB- Kalincik et al. , 2010 -RRB-	34118
@NP	our previous work	34118
@NP	Kalincik	34137
@NP	et al. , 2010	34146
@NP	et al.	34146
@NP	2010	34154
@NP	it	34166
@NP	the treatment with OECs	34186
@NP	the treatment	34186
@NP	OECs	34205
@NP	soma size of the SPNs	34229
@NP	soma size	34229
@NP	the SPNs	34242
@NP	the injury	34261
@NP	the prolonged trend of the SPNs	34281
@NP	the prolonged trend	34281
@NP	the SPNs	34304
@NP	their soma size	34325
@NP	the trauma	34347
@NP	This phenomenon	34371
@NP	a decreased reactivity of the propriospinal circuits	34399
@NP	a decreased reactivity	34399
@NP	the propriospinal circuits	34425
@NP	the injury	34458
@NP	the stimuli	34472
@NP	the abnormal autonomic responses	34495
@NP	their overall impact	34552
@NP	The fact	34574
@NP	similar normalisation in SPN soma size	34588
@NP	similar normalisation	34588
@NP	SPN soma size	34613
@NP	the lesion	34645
@NP	the intact descending regulation	34677
@NP	the rostral SPNs from the supraspinal centres	34713
@NP	the rostral SPNs	34713
@NP	the supraspinal centres	34735
@NP	the OEC-treated animals	34770
@NP	a more permanent increase	34799
@NP	the overall dendritic length of the rostral SPNs	34828
@NP	the overall dendritic length	34828
@NP	the rostral SPNs	34860
@NP	the control animals	34894
@NP	This trend	34915
@NP	first apparent at week 4 -LRB- p = 0.09 , t5 = 1.5 , post-hoc t-test -RRB-	34934
@NP	first	34934
@NP	week 4	34952
@NP	p	34960
@NP	= 0.09 , t5 = 1.5 , post-hoc t-test	34961
@NP	= 0.09	34961
@NP	t5 = 1.5	34968
@NP	t5	34968
@NP	1.5	34971
@NP	post-hoc t-test	34976
@NP	the statistical significance	35009
@NP	week 9	35041
@NP	It	35049
@NP	the increase	35069
@NP	dendritic trees of the rostral SPNs	35085
@NP	dendritic trees	35085
@NP	the rostral SPNs	35104
@NP	the baroreflex	35144
@NP	the episodic arterial hypertension	35180
@NP	the autonomic dysreflexia -LRB- Mathias and Frankel , 1986 -RRB-	35231
@NP	the autonomic dysreflexia	35231
@NP	Mathias and Frankel , 1986	35258
@NP	Mathias and Frankel	35258
@NP	1986	35279
@NP	Larger dendritic arbours	35286
@NP	the regulatory function of SPNs	35328
@NP	the regulatory function	35328
@NP	SPNs	35355
@NP	augmented interconnections	35368
@NP	other neurons of the baroreflex circuits	35400
@NP	other neurons	35400
@NP	the baroreflex circuits	35417
@NP	This hypothesis	35442
@NP	further	35461
@NP	the observation	35482
@NP	no similar changes in the dendritic arbours	35503
@NP	no similar changes	35503
@NP	the dendritic arbours	35525
@NP	The increase in the number of primary dendrites	35566
@NP	The increase	35566
@NP	the number of primary dendrites	35582
@NP	the number	35582
@NP	primary dendrites	35596
@NP	overall dendritic length	35642
@NP	Transplantation of OECs	35668
@NP	Transplantation	35668
@NP	OECs	35687
@NP	any effect	35706
@NP	CGRP	35720
@NP	afferent fibre density	35725
@NP	the dorsal horn of the injured spinal cord neither rostral	35755
@NP	the dorsal horn	35755
@NP	the injured spinal cord neither rostral	35774
@NP	the injured spinal cord	35774
@NP	rostral	35806
@NP	the lesion	35828
@NP	Similar	35840
@NP	the control animals	35851
@NP	the injury-induced increase	35872
@NP	the CGRP fibre density within lamina II of the T7 segment	35903
@NP	the CGRP fibre density	35903
@NP	lamina II of the T7 segment	35933
@NP	lamina II	35933
@NP	the T7 segment	35946
@NP	week 9 post-injury	35976
@NP	week	35976
@NP	the transplantation of the OECs	36027
@NP	the transplantation	36027
@NP	the OECs	36050
@NP	it	36070
@NP	the functional effects of OEC transplantation on autonomic dysreflexia	36090
@NP	the functional effects	36090
@NP	OEC transplantation on autonomic dysreflexia	36116
@NP	OEC transplantation	36116
@NP	autonomic dysreflexia	36139
@NP	CGRP positive primary afferents rostral or caudal to the spinal cord lesion	36195
@NP	CGRP positive primary afferents rostral or caudal	36195
@NP	the spinal cord lesion	36248
@NP	4.3	36272
@NP	Interactions between the OECs and the host	36277
@NP	Interactions	36277
@NP	the OECs and the host	36298
@NP	the OECs	36298
@NP	the host	36311
@NP	nervous tissue	36320
@NP	the present study	36338
@NP	we	36356
@NP	a previously described technique	36364
@NP	an OEC-seeded Gelfoam block	36408
@NP	the transection site	36439
@NP	the traumatic event	36478
@NP	a limited -LRB- i.e. 3 weeks -RRB- survival of OECs at the lesion	36512
@NP	a limited -LRB- i.e. 3 weeks -RRB- survival	36512
@NP	i.e. 3 weeks	36523
@NP	i.e.	36523
@NP	3 weeks	36528
@NP	OECs at the lesion	36549
@NP	OECs	36549
@NP	the lesion	36557
@NP	Kalincik et al. , 2010	36569
@NP	Kalincik	36569
@NP	et al.	36578
@NP	2010	36586
@NP	We	36593
@NP	even this transitory presence of OECs at the injury site	36614
@NP	even this transitory presence	36614
@NP	OECs at the injury site	36647
@NP	OECs	36647
@NP	the injury site	36655
@NP	long-term functional as well as morphological changes	36681
@NP	their survival	36750
@NP	a phenomenon	36765
@NP	Guest et al. , 2008 ; Lopez-Vales et al. , 2006 ; Ramer et al. , 2004	36803
@NP	Guest	36803
@NP	et al. , 2008 ; Lopez-Vales et al. , 2006 ; Ramer et al. , 2004	36809
@NP	et al. , 2008	36809
@NP	et al.	36809
@NP	2008	36817
@NP	Lopez-Vales et al. , 2006	36823
@NP	Lopez-Vales	36823
@NP	et al. , 2006	36835
@NP	et al.	36835
@NP	2006	36843
@NP	Ramer et al. , 2004	36849
@NP	Ramer	36849
@NP	et al. , 2004	36855
@NP	et al.	36855
@NP	2004	36863
@NP	there	36885
@NP	a marked gap	36894
@NP	the period of OEC survival	36915
@NP	the period	36915
@NP	OEC survival	36929
@NP	the observation	36946
@NP	the statistically significant changes in cavity size and in SPN morphology	36965
@NP	the statistically significant changes	36965
@NP	cavity size	37006
@NP	SPN morphology	37025
@NP	the changes in dendritic length and cavity formation	37054
@NP	the changes	37054
@NP	dendritic length and cavity formation	37069
@NP	the observed trends	37108
@NP	4 weeks of transection , i.e. shortly	37156
@NP	4 weeks of transection , i.e.	37156
@NP	4 weeks	37156
@NP	transection	37167
@NP	the OECs	37199
@NP	the host spinal cord	37229
@NP	we	37261
@NP	the observed changes	37279
@NP	they	37328
@NP	week 9	37369
@NP	It	37377
@NP	the model of OEC transplantation that we used in the present study	37411
@NP	the model	37411
@NP	OEC transplantation that we used in the present study	37424
@NP	OEC transplantation	37424
@NP	we	37449
@NP	the present study	37460
@NP	the lesion	37510
@NP	axons	37526
@NP	β-tubulin III	37572
@NP	the previously reported functional improvement	37591
@NP	Kalincik	37639
@NP	et al. , 2010	37648
@NP	et al.	37648
@NP	2010	37656
@NP	reconnection of the transected spinal cord	37686
@NP	reconnection	37686
@NP	the transected spinal cord	37702
@NP	OECs	37730
@NP	neuronal morphology	37759
@NP	both direct contact and secretion	37787
@NP	soluble factors -LRB- Chung et al. , 2004 -RRB-	37824
@NP	soluble factors	37824
@NP	Chung	37841
@NP	et al. , 2004	37847
@NP	et al.	37847
@NP	2004	37855
@NP	our previous study	37865
@NP	we	37884
@NP	migration of the OECs	37899
@NP	migration	37899
@NP	the OECs	37912
@NP	we	37925
@NP	their effects	37943
@NP	the soluble factors	37987
@NP	OECs	38008
@NP	a range	38034
@NP	growth factors such as NGF , brain-derived neurotrophic factor -LRB- BDNF -RRB-	38045
@NP	growth factors	38045
@NP	NGF , brain-derived neurotrophic factor -LRB- BDNF -RRB-	38068
@NP	NGF	38068
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	38073
@NP	brain-derived neurotrophic factor	38073
@NP	BDNF	38108
@NP	glia cell	38118
@NP	line-derived growth factor -LRB- GDNF -RRB- -LRB- Woodhall et al. , 2001 -RRB-	38128
@NP	line-derived growth factor -LRB- GDNF -RRB-	38128
@NP	line-derived growth factor	38128
@NP	GDNF	38156
@NP	Woodhall	38163
@NP	et al. , 2001	38172
@NP	et al.	38172
@NP	2001	38180
@NP	involvement of NGF in the OEC effect	38196
@NP	involvement	38196
@NP	NGF in the OEC effect	38211
@NP	NGF	38211
@NP	the OEC effect	38218
@NP	NGF	38259
@NP	augmented sprouting	38282
@NP	CGRP positive afferent fibres	38305
@NP	Christensen and Hulsebosch	38336
@NP	1997	38364
@NP	our OEC-treated animals	38383
@NP	OECs	38421
@NP	the duration of autonomic dysreflexia -LRB- Kalincik et al. , 2010 -RRB-	38433
@NP	the duration	38433
@NP	autonomic dysreflexia -LRB- Kalincik et al. , 2010 -RRB-	38449
@NP	autonomic dysreflexia	38449
@NP	Kalincik	38472
@NP	et al. , 2010	38481
@NP	et al.	38481
@NP	2010	38489
@NP	primary afferent fibre sprouting	38502
@NP	primary afferent fibre	38502
@NP	its exacerbation -LRB- Krenz et al. , 1999 -RRB-	38551
@NP	its exacerbation	38551
@NP	Krenz	38569
@NP	et al. , 1999	38575
@NP	et al.	38575
@NP	1999	38583
@NP	the other hand	38593
@NP	BDNF and GDNF	38609
@NP	the morphometric properties of SPNs	38646
@NP	the morphometric properties	38646
@NP	SPNs	38677
@NP	BDNF	38683
@NP	an increase	38699
@NP	size of the SPN somata and axons	38714
@NP	size	38714
@NP	the SPN somata and axons	38722
@NP	the SPN somata	38722
@NP	axons	38741
@NP	synaptic input to postganglionic neurons -LRB- Causing et al. , 1997 -RRB-	38761
@NP	synaptic input	38761
@NP	postganglionic neurons	38779
@NP	et al. , 1997	38811
@NP	et al.	38811
@NP	1997	38819
@NP	GDNF	38832
@NP	SPNs	38865
@NP	target-deprived cell death -LRB- Schober et al. , 1999 -RRB-	38875
@NP	target-deprived cell death	38875
@NP	Schober	38903
@NP	et al. , 1999	38911
@NP	et al.	38911
@NP	1999	38919
@NP	release of BDNF and GDNF by transplanted OECs	38936
@NP	release	38936
@NP	BDNF and GDNF by transplanted OECs	38947
@NP	BDNF and GDNF	38947
@NP	transplanted OECs	38964
@NP	a potential mechanism for their effect	38996
@NP	a potential mechanism	38996
@NP	their effect	39022
@NP	SPNs	39038
@NP	the spinal cord tissue preservation described here	39059
@NP	the spinal cord tissue preservation	39059
@NP	We	39111
@NP	the differential effect	39145
@NP	OEC treatment on the SPNs rostral and caudal to the SCI	39172
@NP	OEC treatment	39172
@NP	the SPNs rostral and caudal to the SCI	39189
@NP	the SPNs rostral and caudal	39189
@NP	the SCI	39220
@NP	a difference in the activity-dependent demand for trophic factors	39242
@NP	a difference	39242
@NP	the activity-dependent demand for trophic factors	39258
@NP	the activity-dependent demand	39258
@NP	trophic factors	39292
@NP	the injury	39324
@NP	The SPNs rostral to the injury	39336
@NP	The SPNs rostral	39336
@NP	the injury	39356
@NP	innervation	39394
@NP	an organised manner under the control of supraspinal centres	39427
@NP	an	39427
@NP	manner	39440
@NP	the control of supraspinal centres	39453
@NP	the control	39453
@NP	supraspinal centres	39468
@NP	contrast	39492
@NP	SPNs	39502
@NP	the transection loose	39517
@NP	the transection	39517
@NP	their descending inputs	39539
@NP	the role	39589
@NP	the rostral SPNs	39601
@NP	the compensation for low baseline blood pressure and dysreflexic hypertension	39621
@NP	the compensation	39621
@NP	low baseline blood pressure and dysreflexic hypertension	39642
@NP	low baseline blood pressure	39642
@NP	dysreflexic hypertension	39674
@NP	it	39710
@NP	the demand	39730
@NP	the rostral SPNs for neurotrophic factors	39744
@NP	the rostral SPNs	39744
@NP	neurotrophic factors	39765
@NP	the overall effect of these factors on their morphology and function	39797
@NP	the overall effect	39797
@NP	these factors on their morphology and function	39819
@NP	these factors	39819
@NP	their morphology and function	39836
@NP	that of the SPNs caudal to the injury	39879
@NP	that	39879
@NP	the SPNs caudal to the injury	39887
@NP	the SPNs	39887
@NP	the injury	39906
@NP	Such activity dependence	39918
@NP	development	39964
@NP	neurotrophins	39982
@NP	modulators	40003
@NP	activity-dependent plasticity -LRB- reviewed in Bibel and Barde , 2000 -RRB-	40017
@NP	activity-dependent plasticity	40017
@NP	Bibel and Barde , 2000	40060
@NP	Bibel and Barde	40060
@NP	2000	40077
@NP	instance	40088
@NP	the effect of BDNF on dendritic length and branching in retinal ganglion cells	40098
@NP	the effect	40098
@NP	BDNF	40112
@NP	dendritic length	40120
@NP	retinal ganglion cells	40154
@NP	their activity -LRB- Cohen-Cory , 1999 -RRB-	40188
@NP	their activity	40188
@NP	Cohen-Cory	40204
@NP	1999	40216
@NP	contrast to the specific effects of OECs on SPN morphology	40226
@NP	contrast	40226
@NP	the specific effects of OECs on SPN morphology	40238
@NP	the specific effects	40238
@NP	OECs on SPN morphology	40262
@NP	OECs	40262
@NP	SPN morphology	40270
@NP	the effect of OEC transplantation on cavity formation	40286
@NP	the effect	40286
@NP	OEC transplantation on cavity formation	40300
@NP	OEC transplantation	40300
@NP	cavity formation	40323
@NP	the lesion	40367
@NP	This	40379
@NP	OECs	40398
@NP	cavitation	40420
@NP	a more general neuroprotective mechanism	40435
@NP	modulation of inflammation -LRB- Lopez-Vales et al. , 2006 -RRB-	40485
@NP	modulation	40485
@NP	inflammation -LRB- Lopez-Vales et al. , 2006 -RRB-	40499
@NP	inflammation	40499
@NP	Lopez-Vales	40513
@NP	et al. , 2006	40525
@NP	et al.	40525
@NP	2006	40533
@NP	The present work	40540
@NP	some	40566
@NP	the potential mechanisms	40574
@NP	transplantation of OECs	40613
@NP	transplantation	40613
@NP	OECs	40632
@NP	the amelioration of autonomic dysreflexia in spinal cord-injured animals	40652
@NP	the amelioration	40652
@NP	autonomic dysreflexia in spinal cord-injured animals	40672
@NP	autonomic dysreflexia	40672
@NP	spinal cord-injured animals	40697
@NP	cellular therapies for SCI	40732
@NP	cellular therapies	40732
@NP	SCI	40755
@NP	significant scientific attention	40773
@NP	clinical trials undertaken	40811
@NP	clinical trials	40811
@NP	Mackay-Sim	40839
@NP	et al. , 2008	40850
@NP	et al.	40850
@NP	2008	40858
@NP	research on effects other than merely locomotion	40865
@NP	research	40865
@NP	effects other than merely locomotion	40877
@NP	effects	40877
@NP	merely locomotion	40896
@NP	safety	40941
@NP	human subjects	40951
@NP	more scientific work	40976
@NP	the mechanisms of OEC actions	41014
@NP	the mechanisms	41014
@NP	OEC actions	41032
@NP	these functions	41047
@VP	include facilitation of regeneration and neuroprotection	767
@VP	reduce the duration of autonomic dysreflexia , without evidence of regeneration	890
@VP	To further understand the mechanisms underpinning this improvement	970
@VP	further understand the mechanisms underpinning this improvement	973
@VP	underpinning this improvement	1007
@VP	caudal to the lesion	1620
@VP	remains intact	2137
@VP	mediated through secretion of soluble trophic factors by the transplanted OECs	2191
@VP	1	2272
@VP	resulting in impairment of sensory , motor and autonomic functions	2369
@VP	not directly disrupted by the traumatic event	2760
@VP	may lead to serious consequences and death	3426
@VP	lead to serious consequences and death	3430
@VP	sprouting of primary afferent fibres	4013
@VP	have not yet been studied after high thoracic transection	4050
@VP	been studied after high thoracic transection	4063
@VP	studied after high thoracic transection	4068
@VP	assessed the effects of OEC transplantation on these morphological features	4379
@VP	2	4457
@VP	weighing 350 -- 400 g.	4904
@VP	were housed separately in plastic home boxes -LRB- 65 × 40 × 22 cm -RRB-	4936
@VP	housed separately in plastic home boxes -LRB- 65 × 40 × 22 cm -RRB-	4941
@VP	were provided with ad-lib food and water	4996
@VP	provided with ad-lib food and water	5001
@VP	maintained on a 12-h light/dark cycle	5041
@VP	expressing OECs	5146
@VP	were prepared as described -LRB- Kalincik et al. , 2010 -RRB-	5162
@VP	described -LRB- Kalincik et al. , 2010 -RRB-	5179
@VP	harvested from Australian Albino Wistar male rats	5248
@VP	dissociated in 0.25 % collagenase type IA	5319
@VP	enhance survival of OECs in culture	5423
@VP	increase their purity to close to 100 % -LRB- Bianco et al. , 2004 -RRB-	5463
@VP	to close to 100 % -LRB- Bianco et al. , 2004 -RRB-	5485
@VP	close to 100 % -LRB- Bianco et al. , 2004 -RRB-	5488
@VP	was carried out as previously	6428
@VP	carried out as previously	6432
@VP	described -LRB- Kalincik et al. , 2010 -RRB-	6458
@VP	was carried out	6915
@VP	carried out	6919
@VP	was completely transected with microscissors at the level of T4	6951
@VP	transected with microscissors at the level of T4	6966
@VP	containing OECs -LRB- 500,000 cells/μl -RRB-	7258
@VP	soaked in 2 μl of culture medium	7338
@VP	was used	7376
@VP	used	7380
@VP	to separate the nervous tissue from surrounding connective tissue	7461
@VP	separate the nervous tissue from surrounding connective tissue	7464
@VP	surrounding connective tissue	7497
@VP	was closed	7541
@VP	closed	7545
@VP	were kept at 27 °C	7609
@VP	kept at 27 °C	7614
@VP	were administered subcutaneously twice daily for 5 days	7739
@VP	administered subcutaneously twice daily for 5 days	7744
@VP	were given twice daily for 3 days	7903
@VP	given twice daily for 3 days	7908
@VP	expressed 2	7970
@VP	gradually reestablished	8039
@VP	was carried out daily	8140
@VP	carried out daily	8144
@VP	soiled	8163
@VP	were bathed	8178
@VP	bathed	8183
@VP	treated	8207
@VP	anaesthetised with pentobarbitone	8365
@VP	were perfused using the same procedure	8570
@VP	perfused using the same procedure	8575
@VP	using the same procedure	8584
@VP	collected	8642
@VP	postfixed in 4 % paraformaldehyde -LRB- 2 h -RRB-	8653
@VP	cryoprotected in 30 % sucrose -LRB- 24 h -RRB-	8696
@VP	were cut on a cryostat into 35 μm thick horizontal sections	8752
@VP	cut on a cryostat into 35 μm thick horizontal sections	8757
@VP	were mounted onto gelatinised slides , air-dried and stored at − 22 °C	8826
@VP	were mounted onto gelatinised slides , air-dried	8826
@VP	mounted onto gelatinised slides , air-dried	8831
@VP	stored at − 22 °C	8878
@VP	were stained for NADPH-diaphorase	8926
@VP	stained for NADPH-diaphorase	8931
@VP	were stained with hematoxylin-eosin	8972
@VP	stained with hematoxylin-eosin	8977
@VP	was stained for GFP	9020
@VP	stained for GFP	9024
@VP	was left unstained for the examination of unlabelled GFP	9055
@VP	left unstained for the examination of unlabelled GFP	9059
@VP	cut on a cryostat into 35 μm thick transverse sections	9137
@VP	stained for calcitonin-gene related peptide -LRB- CGRP -RRB-	9196
@VP	carried out according to a standard protocol -LRB- Carrive and Paxinos , 1994	9356
@VP	washed in phosphate buffered saline for 1 h	9476
@VP	incubated in 0.05 % solution of NADPH -LRB- reduced NADPH , Sigma-Aldrich Pty.	9524
@VP	was first incubated for 2 h at 37 °C and then left at room temperature for 4 h.	9738
@VP	was first incubated for 2 h at 37 °C	9738
@VP	first incubated for 2 h at 37 °C	9742
@VP	then left at room temperature for 4 h.	9779
@VP	was terminated by rinses in phosphate buffer and distilled water	9831
@VP	terminated by rinses in phosphate buffer and distilled water	9835
@VP	cleared in 100 % ethanol for 4 -- 6 h	9936
@VP	mounted with DAKO	9971
@VP	visualised with a light microscope -LRB- Olympus BX51 + DP70 -RRB-	9993
@VP	was prepared against synthetic rat CGRP	10270
@VP	prepared against synthetic rat CGRP	10274
@VP	had been described -LRB- Brejot et al. , 2006 -RRB-	10358
@VP	been described -LRB- Brejot et al. , 2006 -RRB-	10362
@VP	described -LRB- Brejot et al. , 2006 -RRB-	10367
@VP	prepared against full-length humanised R. reniformis GFP purified from E. coli	10508
@VP	purified from E. coli	10565
@VP	had been observed -LRB- Han et al. , 2006 -RRB-	10629
@VP	been observed -LRB- Han et al. , 2006 -RRB-	10633
@VP	observed -LRB- Han et al. , 2006 -RRB-	10638
@VP	cleared in xylene and 100 % ethanol	10701
@VP	rehydrated	10737
@VP	containing 0.3 % Triton-X	10809
@VP	buffered saline-Triton-X solution containing 10 %	10907
@VP	containing 10 %	10941
@VP	buffered saline	11081
@VP	was visualised with a fluorescent microscope -LRB- Olympus BX51 + DP70 -RRB-	11819
@VP	visualised with a fluorescent microscope -LRB- Olympus BX51 + DP70 -RRB-	11823
@VP	using ImageJ software	12095
@VP	stained with hematoxylin-eosin	12210
@VP	were selected	12308
@VP	selected	12313
@VP	extrapolated from the lateral edges of the horizontal section at y	12560
@VP	extended to x.	12631
@VP	to x.	12640
@VP	x.	12643
@VP	Using a similar approach	12646
@VP	was defined -LRB- Fig. 1 , lines w and z -RRB-	12714
@VP	defined -LRB- Fig. 1 , lines w and z -RRB-	12718
@VP	w and z	12741
@VP	completely bordered by spinal cord tissue	12861
@VP	defined as fibrosis or shrinkage of the cord edges	12937
@VP	expressed as a percentage of the total rostral or caudal area of interest	13106
@VP	were analysed as described previously	13344
@VP	analysed as described previously	13349
@VP	described previously	13361
@VP	were examined and 9 -- 10 neurons located rostral -LRB- T2 -- T3 -RRB- and 9	13484
@VP	examined and 9 -- 10 neurons located rostral -LRB- T2 -- T3 -RRB- and 9	13489
@VP	were measured using ImageJ software	13594
@VP	measured using ImageJ software	13599
@VP	using ImageJ software	13608
@VP	were measured within one 35 μm thick horizontal section	13670
@VP	measured within one 35 μm thick horizontal section	13675
@VP	were assessed	13797
@VP	assessed	13802
@VP	being within 2 segments from the injury site	13946
@VP	were recorded	14107
@VP	recorded	14112
@VP	were compared between OEC-treated , control and intact animals	14267
@VP	compared between OEC-treated , control and intact animals	14272
@VP	stained for CGRP	14444
@VP	was performed on transverse sections from T1 and T7 using ImageJ software	14461
@VP	performed on transverse sections from T1 and T7 using ImageJ software	14465
@VP	using ImageJ software	14513
@VP	Rexed laminae	14536
@VP	were identified with the help of the atlas of rat	14550
@VP	identified with the help of the atlas of rat	14555
@VP	was recorded within a 10,000 μm2 square selection at the lamina VII	14723
@VP	recorded within a 10,000 μm2 square selection at the lamina VII	14727
@VP	was subtracted from each image	14797
@VP	subtracted from each image	14801
@VP	were then thresholded using uniform criteria -LRB- Fig. 3 -RRB-	14843
@VP	thresholded using uniform criteria -LRB- Fig. 3 -RRB-	14853
@VP	using uniform criteria -LRB- Fig. 3 -RRB-	14865
@VP	was superimposed over laminae I -- V , giving 5 selections per lamina	14952
@VP	superimposed over laminae I -- V , giving 5 selections per lamina	14956
@VP	giving 5 selections per lamina	14987
@VP	was recorded	15094
@VP	recorded	15098
@VP	were averaged per lamina and animal	15125
@VP	averaged per lamina and animal	15130
@VP	carried out in the intact animals	15227
@VP	included in this study	15293
@VP	have been included in the present manuscript -LRB- Kalincik et al. , 2010 -RRB-	15499
@VP	been included in the present manuscript -LRB- Kalincik et al. , 2010 -RRB-	15504
@VP	included in the present manuscript -LRB- Kalincik et al. , 2010 -RRB-	15509
@VP	offer a comparison of the early changes with those seen at longer survival times	15595
@VP	seen at longer survival times	15646
@VP	operated by the same surgeon and with protocols identical to those used here	15725
@VP	used here	15792
@VP	describing the morphometric features of SPNs	15812
@VP	describing the injury size at 9 weeks post-injury	15904
@VP	are novel	15954
@VP	were not collected	16093
@VP	collected	16102
@VP	were carried out by a researcher	16157
@VP	carried out by a researcher	16162
@VP	blinded to the treatment	16190
@VP	are expressed throughout as mean ± SEM	16221
@VP	expressed throughout as mean ± SEM	16225
@VP	was used for all statistical analyses	16325
@VP	used for all statistical analyses	16329
@VP	were considered significant if p ≤ 0.05	16372
@VP	considered significant if p ≤ 0.05	16377
@VP	were compared with a two-way ANOVA	16877
@VP	compared with a two-way ANOVA	16882
@VP	was examined with a linear regression analysis	16986
@VP	examined with a linear regression analysis	16990
@VP	to estimate fixed and random effects -LRB- Kalincik et al. , 2010 -RRB-	17247
@VP	estimate fixed and random effects -LRB- Kalincik et al. , 2010 -RRB-	17250
@VP	were considered fixed	17365
@VP	considered fixed	17370
@VP	fixed	17381
@VP	was considered random	17410
@VP	considered random	17414
@VP	was assumed for all pairs of measurements on the same animal	17560
@VP	assumed for all pairs of measurements on the same animal	17564
@VP	3	17781
@VP	drawn 2 mm rostrally -LRB- y -RRB-	18153
@VP	were defined as parallel lines drawn from the lateral edges of lines y or z	18246
@VP	defined as parallel lines drawn from the lateral edges of lines y or z	18251
@VP	drawn from the lateral edges of lines y or z	18277
@VP	extended towards the lesion to meet lines x or w.	18327
@VP	to meet lines x or w.	18355
@VP	meet lines x or w.	18358
@VP	stained for NADPHdiaphorase	18529
@VP	are apparent on the lateral aspects of the grey matter rostral and Fig. 3	18643
@VP	recorded in Rexed lamina VII	18788
@VP	was subtracted from the image	18833
@VP	subtracted from the image	18837
@VP	superimposed as a grid over the section	18949
@VP	were assessed	19002
@VP	assessed	19007
@VP	analysed separately	19424
@VP	OECtreated	19785
@VP	found in all three analysed features -LRB- pb0 .03 , linear mixed model -RRB-	19844
@VP	was found in lamina II -LRB- p = 0.04 , three-way ANOVA -RRB-	20118
@VP	found in lamina II -LRB- p = 0.04 , three-way ANOVA -RRB-	20122
@VP	reported previously by our lab	20221
@VP	transplanted into the transection site within a Gelfoam block	20258
@VP	were abundant within the transplant at week 1	20320
@VP	had disappeared by 4 weeks post-injury -LRB- Kalincik et al. , 2010 -RRB-	20371
@VP	disappeared by 4 weeks post-injury -LRB- Kalincik et al. , 2010 -RRB-	20375
@VP	Following the T4 transection	20452
@VP	increased with time postinjury in the segments rostral and caudal to the SCI	20757
@VP	increasing to 10 % by week 4 and to over 20 % by week 9	20911
@VP	amounted to about 10 % of the delineated rostral and caudal areas	21425
@VP	to about 10 % of the delineated rostral and caudal areas	21434
@VP	about 10 % of the delineated rostral and caudal areas	21437
@VP	delineated rostral and caudal areas	21454
@VP	can be seen in Fig. 4	21494
@VP	be seen in Fig. 4	21498
@VP	seen in Fig. 4	21501
@VP	were seen	22025
@VP	seen	22030
@VP	was examined	22215
@VP	examined	22219
@VP	shown by a linear regression analysis -LRB- R2 = 10 − 6 ; p = 0.99 -RRB-	22285
@VP	recorded in the intact and the control groups -LRB- Fig. 5 -RRB-	22454
@VP	was more pronounced rostrally	22638
@VP	was apparent throughout the 9 weeks following transection	22672
@VP	showed a similar trend to increase after SCI	22777
@VP	to increase after SCI	22800
@VP	increase after SCI	22803
@VP	was more pronounced rostrally than caudally	22846
@VP	resembling those in the intact animals	23027
@VP	To evaluate the effect ofOEC transplantation	23514
@VP	evaluate the effect ofOEC transplantation	23517
@VP	were compared to those in the control groups -LRB- Fig. 5 -RRB-	23613
@VP	did not differ between the groups	23704
@VP	differ between the groups	23712
@VP	were smaller at week 9 post-injury	23792
@VP	atweek 9 post-injury	24084
@VP	was seen at week 1 after SCI	24384
@VP	seen at week 1 after SCI	24388
@VP	was reversed at the later time-points	24433
@VP	reversed at the later time-points	24437
@VP	did not return to the pre-injury levels	24902
@VP	return to the pre-injury levels	24910
@VP	compared to the control groups	25118
@VP	increased after SCI in both rostral and caudal segments	25513
@VP	persisted for 9 weeks for soma size	25584
@VP	caused a reduction towards pre-injury values for caudal soma size	25784
@VP	was not available for this analysis	26266
@VP	can be seen in Fig. 6	26307
@VP	be seen in Fig. 6	26311
@VP	seen in Fig. 6	26314
@VP	found in laminae III -- V.	26444
@VP	to increase with time in laminae I -- IV , particularly caudal to the lesion	26511
@VP	increase with time in laminae I -- IV , particularly caudal to the lesion	26514
@VP	was observed in SPNs rostral or caudal to the lesion	26850
@VP	observed in SPNs rostral or caudal to the lesion	26854
@VP	were only minor and lacking any consistent trends	26967
@VP	lacking any consistent trends	26987
@VP	was confirmed with a three-way ANOVA -LRB- p ≥ 0.2 , F2 ,29 ≤ 1.8 -RRB-	27035
@VP	confirmed with a three-way ANOVA -LRB- p ≥ 0.2 , F2 ,29 ≤ 1.8 -RRB-	27039
@VP	4	27093
@VP	Using the rat model of T4 transection	27107
@VP	expanding cavities both rostral and caudal to the lesion	27210
@VP	occurs early after the insult and does not evolve further	27318
@VP	occurs early after the insult	27318
@VP	does not evolve further	27352
@VP	evolve further	27361
@VP	alter the changes in SPNs above and below the injury	27667
@VP	affecting the sprouting of CGRP-positive afferent fibres	27775
@VP	have shown that transection of the spinal cord results in formation of cavities	27911
@VP	shown that transection of the spinal cord results in formation of cavities	27916
@VP	results in formation of cavities	27958
@VP	evidenced by narrowing of the cord near the injury site	28046
@VP	occur within 1 week of the traumatic event	28156
@VP	evolve over at least 9 weeks	28231
@VP	remains constant from 1 week post-injury	28307
@VP	is independent of the expanding cavitation	28403
@VP	be the direct result of retraction of the cut stumps at the time of transection	28454
@VP	represents a sensitive marker of the spread of secondary injury	28569
@VP	is one of the principal obstacles of the spinal cord regeneration	28637
@VP	are temporary , resolving within 9 weeks of SCI	28909
@VP	resolving within 9 weeks of SCI	28924
@VP	is apparent at least until 9 weeks post-injury	29032
@VP	do not differ above	29254
@VP	differ above	29261
@VP	labelled from the adrenal medulla	29339
@VP	differ from ours in several critical aspects	29505
@VP	were decreased 1 week after injury -LRB- Krassioukov and Weaver , 1995 -RRB-	29693
@VP	decreased 1 week after injury -LRB- Krassioukov and Weaver , 1995 -RRB-	29698
@VP	reported that these caudal changes were reversed by 2 weeks	29774
@VP	were reversed by 2 weeks	29809
@VP	reversed by 2 weeks	29814
@VP	seemed to confirm this	29900
@VP	to confirm this	29907
@VP	confirm this	29910
@VP	was not quantified -LRB- Krassioukov and Weaver , 1996 -RRB-	29927
@VP	quantified -LRB- Krassioukov and Weaver , 1996 -RRB-	29935
@VP	remain unclear	30028
@VP	were used	30142
@VP	used	30147
@VP	compared studies	30161
@VP	involved measurements of the same morphological features	30178
@VP	projecting to the adrenal gland	30261
@VP	were apparent -LRB- but not quantified -RRB-	30404
@VP	quantified	30427
@VP	visualised by NADPH staining	30451
@VP	used here	30484
@VP	contributing to the development of autonomic dysreflexia	30536
@VP	may then represent an attempt to regain lost synapses	31059
@VP	represent an attempt to regain lost synapses	31068
@VP	to regain lost synapses	31089
@VP	regain lost synapses	31092
@VP	reported on SPNs -LRB- Llewellyn-Smith and Weaver , 2001 -RRB-	31182
@VP	here tested within the segment T7	31378
@VP	sprouting	31755
@VP	caudal to the lesion	31885
@VP	sprouting	31912
@VP	is known to be augmented by nerve growth factor -LRB- NGF -RRB-	31922
@VP	known to be augmented by nerve growth factor -LRB- NGF -RRB-	31925
@VP	to be augmented by nerve growth factor -LRB- NGF -RRB-	31931
@VP	be augmented by nerve growth factor -LRB- NGF -RRB-	31934
@VP	augmented by nerve growth factor -LRB- NGF -RRB-	31937
@VP	have been deprived of their descending regulatory inputs from supraspinal nuclei	32096
@VP	been deprived of their descending regulatory inputs from supraspinal nuclei	32101
@VP	deprived of their descending regulatory inputs from supraspinal nuclei	32106
@VP	triggered by the SCI	32440
@VP	reached at week 9 when analysed separately from the other two time-points	33172
@VP	analysed separately from the other two time-points	33195
@VP	have a protective effect on the nervous tissue adjacent to the lesion	33272
@VP	described elsewhere -LRB- Kalincik et al. , 2010 -RRB-	33474
@VP	here quantified as non-cavity tissue loss	33579
@VP	is not influenced by the OEC transplantation	33622
@VP	influenced by the OEC transplantation	33629
@VP	develops immediately after the traumatic event and thereafter remains static	33724
@VP	develops immediately after the traumatic event	33724
@VP	thereafter remains static	33775
@VP	become obvious only days or weeks after SCI	33906
@VP	initiated by the spinal cord transection	33992
@VP	was shown in the data from our previous work -LRB- Kalincik et al. , 2010 -RRB-	34091
@VP	shown in the data from our previous work -LRB- Kalincik et al. , 2010 -RRB-	34095
@VP	to increase their soma size after the trauma is reversed	34313
@VP	increase their soma size after the trauma is reversed	34316
@VP	is reversed	34358
@VP	reversed	34361
@VP	triggering the abnormal autonomic responses	34484
@VP	thus may attenuate their overall impact	34533
@VP	attenuate their overall impact	34542
@VP	is not seen above the lesion	34627
@VP	seen above the lesion	34634
@VP	compared to the control animals	34882
@VP	reaching the statistical significance at week 9	35000
@VP	are involved in the baroreflex	35128
@VP	involved in the baroreflex	35132
@VP	associated with the autonomic dysreflexia -LRB- Mathias and Frankel , 1986 -RRB-	35215
@VP	are seen caudally	35547
@VP	seen caudally	35551
@VP	resembles that described in overall dendritic length	35614
@VP	described in overall dendritic length	35629
@VP	is apparent at week 9 post-injury	35961
@VP	is not further modulated by the transplantation of the OECs	35999
@VP	modulated by the transplantation of the OECs	36014
@VP	yields a limited -LRB- i.e. 3 weeks -RRB- survival of OECs at the lesion	36505
@VP	outlast their survival	36742
@VP	are last observed in the host spinal cord	37208
@VP	observed in the host spinal cord	37217
@VP	begin to evolve well before they become statistically significant at week 9	37300
@VP	to evolve well before they become statistically significant at week 9	37306
@VP	evolve well before they become statistically significant at week 9	37309
@VP	become statistically significant at week 9	37333
@VP	used in the present study	37452
@VP	demonstrated before by staining for β-tubulin III	37536
@VP	staining for β-tubulin III	37559
@VP	can not be attributed to reconnection of the transected spinal cord	37662
@VP	be attributed to reconnection of the transected spinal cord	37669
@VP	attributed to reconnection of the transected spinal cord	37672
@VP	did not see migration of the OECs	37887
@VP	see migration of the OECs	37895
@VP	suggested that their effects are probably mediated through the soluble factors	37928
@VP	are probably mediated through the soluble factors	37957
@VP	mediated through the soluble factors	37970
@VP	not seen in our OEC-treated animals	38371
@VP	sprouting	38525
@VP	would result in its exacerbation -LRB- Krenz et al. , 1999 -RRB-	38535
@VP	result in its exacerbation -LRB- Krenz et al. , 1999 -RRB-	38541
@VP	are known to influence the morphometric properties of SPNs	38623
@VP	known to influence the morphometric properties of SPNs	38627
@VP	to influence the morphometric properties of SPNs	38633
@VP	influence the morphometric properties of SPNs	38636
@VP	stimulates an increase in size of the SPN somata and axons	38688
@VP	Causing et al. , 1997	38803
@VP	protect SPNs from target-deprived cell death -LRB- Schober et al. , 1999 -RRB-	38857
@VP	described here	39095
@VP	maintain intact descending innervation	39367
@VP	descending innervation	39383
@VP	are activated in an organised manner under the control of supraspinal centres	39410
@VP	activated in an organised manner under the control of supraspinal centres	39414
@VP	organised manner under the control of supraspinal centres	39430
@VP	differs from that of the SPNs caudal to the injury	39866
@VP	caudal to the injury	39896
@VP	reviewed in Bibel and Barde , 2000	40048
@VP	branching in retinal ganglion cells	40141
@VP	depends on their activity -LRB- Cohen-Cory , 1999 -RRB-	40177
@VP	is similar above and below the lesion	40340
@VP	undertaken	40827
@VP	is important for assessing safety in human subjects	40914
@VP	assessing safety in human subjects	40931
@VP	is needed before the mechanisms of OEC actions on these functions	40997
@VP	needed before the mechanisms of OEC actions on these functions	41000
@VP	are elucidated	41063
@VP	elucidated	41067
